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1 Introduction 
1.1 Palliative Care 
WĂůůŝĂƚŝǀĞĐĂƌĞŝƐĚĞĨŝŶĞĚďǇƚŚĞtŽƌůĚ,ĞĂůƚŚKƌŐĂŶŝǌĂƚŝŽŶĂƐ “ĂŶĂƉƉƌŽĂĐŚƚŚĂƚŝŵƉƌŽǀĞƐƚŚĞƋƵĂůŝƚǇ
of life of patients and their families facing the problems associated with life-threatening illness, 
through the prevention and relief of suffering by means of early identification and impeccable 
ĂƐƐĞƐƐŵĞŶƚ ĂŶĚ ƚƌĞĂƚŵĞŶƚ ŽĨ ƉĂŝŶ ĂŶĚ ŽƚŚĞƌ ƉƌŽďůĞŵƐ ? ƉŚǇƐŝĐĂů ? ƉƐǇĐŚŽƐŽĐŝĂů ĂŶĚ ƐƉŝƌŝƚƵĂů ? ?
Palliative care is holistic in nature and it focuses on the support of the patient and their family, and 
not just the disease (1).  
 
Palliative care does not to cure the patient of their disease but aims to make the experience less 
distressing and more tolerable. The aim of palliative care is to therefore provide the best possible 
healthcare services to the patient, to positively influence the natural course of the illness, and to 
offer support to allow them to live as actively as possible until death.  Palliative care provides relief 
from pain and other symptoms, and aims to manage and reduce any adverse side effects of the 
medications required at that time.   It maximises the quality of life for patients and families from the 
beginning to the end of the disease trajectory.  
 
At present in Scotland, 90% of specialist palliative care is supporting patients with cancer (2).  
However, other long term conditions such as heart failure, COPD and dementia also incorporate 
aspects of palliative care in their management (3, 4).  
 
1.2  Scottish Policy  
1.2.1 Public Health Policy Context 
Audit Scotland ?ƐƌĞǀŝĞǁŽĨpalliative care provision in Scotland found a lack of coordinated national 
strategy for palliative care (5). The key messages from this report included:  
x Significant variation exists across Scotland in the availability of specialist palliative care 
services 
x People with a range of conditions need specialist palliative care but it remains primarily 
cancer-focused 
x Generalists need increased skills, confidence and support from specialists to improve the 
palliative care they give to patients and their families 
x Palliative care needs to be better joined up, particularly at night and weekends 
x Family and friends caring for someone with palliative care needs also need support but this 
is not widely available. 
 
Within Scotland,  the aim is for services to develop for  patients with palliative care needs regardless 
of their diagnosis, location or care setting as ŚŝŐŚůŝŐŚƚĞĚƚŚƌŽƵŐŚƚŚĞ ‘>ŝǀŝŶŐ ?ǇŝŶŐtĞůů ?ŝŶŝƚŝĂ ǀĞ 
(2, 6). The action plan states that NHS Health Boards and Community Health Partnerships (CHPs) 
should ensure that patients with palliative care needs are included in a palliative care register and 
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are supported by a multidisciplinary team (MDT).  The action plan also emphasises the importance 
of anticipatory care in order to avoid any unnecessary crises during the out-of-hours period.   
 
1.2.2 Pharmacy Policy Context 
'The Right Medicine: A Strategy for Pharmaceutical Care in Scotland' was published in 2002 by the 
Scottish Government. This policy document proƉŽƐĞĚ ďĞƚƚĞƌ ƵƐĞ ŽĨ ƉŚĂƌŵĂĐŝƐƚƐ ? ƉƌŽĨĞƐƐŝŽŶĂů
competence in planning and delivering services, including areas such as cancer and heart disease (7).  
This resulted in all NHS Scotland Health Boards setting up Community Pharmacy Palliative Care 
Networks (CPPCN).  More importantly, the recently published government policy  ‘WƌĞƐĐƌŝƉƚŝŽŶ ĨŽƌ
ǆĐĞůůĞŶĐĞ ?(8) states that by 2023 all pharmacists will be NHS accredited clinical pharmacist 
independent prescribers. As well as this increased role in providing clinical care in the community, 
pharmacists will work in partnership with the medical profession caring for patients with long term 
conditions. Increasing the involvement of the pharmacist in both primary and secondary care is part 
of the action plan proposed through this initiative.  
 
Within the NHS Highland, 58 of the 78 pharmacies are currently part of the CPPCN. This means that 
they should: retain a stock of  specific  palliative medicines; arrange delivery of urgent prescriptions 
and medicines to palliative patients when required; attend and declare attendance of on-going 
palliative training and education sessions; and provide advice and support to patients, carers, 
pharmacies, GPs and district nurses in relation to palliative care delivery.  
 
1.3 Palliative Care Challenges Faced In the Rural Environment 
Rural populations are generally found to consist of an older demographic, have less disposable 
income and present with diseases at a later stage than urban populations (9, 10). In addition, 
particular challenges can be faced in terms of planning, delivering and accessing (palliative) care and 
services due to local geography and the dispersed nature of rural populations.  
 
1.3.1 Geography 
The geography associated with rural areas can make it harder to deliver healthcare services as seen 
in the remote parts of Australia (11). This can be compounded by issues such as poorer quality 
roads/infrastructure, more expensive fuel and extreme weather conditions (12). However, it has 
been argued that much of the previous focus of remote palliative care research has been limited in 
terms of assuming that poor access to services is purely due to the aforementioned  geographical 
limitations (13). Rural communities may need tailored palliative care services operating 
independently from those in urban settings. Within Scotland, a greater understanding of the needs 
of rural communities would allow suitable tailor-made services based upon the needs as well as the 
capabilities of the community.   
 
1.3.2 Confidentiality 
Due to the small size of rural populations, healthcare professionals may already be known to 
patients / carers as neighbours and friends (14-17). These informal networks may be beneficial for 
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patients receiving palliative care in ensuring that they are not overlooked, particularly if services are 
limited or stretched.  The support of the local community is also helpful, as neighbours may be more 
receptive to other ŶĞŝŐŚďŽƵƌƐ ? ŶĞĞĚƐunlike bigger communities who may not be as familiar with 
one another (18). Healthcare professionals also appear to go to great lengths to provide care in rural 
settings, with many going above and beyond the normal call of duty; sometimes risking their own 
safety or working around particular rules/ways of working (18). However, specific challenges exist to 
ĞŶƐƵƌĞƚŚĂƚĂƉĂƚŝĞŶƚ ?ƐƌŝŐŚƚƚŽĐŽŶĨŝĚĞŶƚŝĂůŝƚǇŝƐĞŶƐŚƌŝŶĞĚǁŝƚŚŝŶƉĂůůŝĂƚŝǀĞĐĂƌĞ ? 
 
1.3.3 Communication 
Due to the logistical restrictions the geography of a rural area can present (e.g. large distances, 
sparse population, and long travelling times) regular face-to-face meetings between patients and 
healthcare professionals are not always possible. Other means of communication and service 
delivery must be provided. Services ŵĂǇĚĞƉĞŶĚŽŶŽŶĞŝŶĚŝǀŝĚƵĂůŽƌ ‘ĐŚĂŵƉŝŽŶ ? for maintaining the 
service, which can raise issues around service reliability and sustainability (18).  
 
In Australia, the Caring Communities Programme awarded the Toowoomba Division of General 
Practices and the Toowoomba Hospice funding for the support, education, assessment and 
monitoring (SEAM) project, which aimed to improve the quality of palliative care in the community 
through supporting families, carers and healthcare professionals (11). The project offered good 
sources of advice and information, and the networking and liaising opportunities for both healthcare 
professionals and patients were noted. There did seem to be a positive association between the 
level of awareness of the project and the perceived success of it.  
 
1.4 Pharmacy-Based Palliative Care Services 
1.4.1 Community Pharmacy Palliative Care Services  
The pharmacist is a core member of the specialist palliative care team (19, 20). While many papers 
describe the role of the pharmacist within palliative care, only some consider this role within the 
community setting where the majority of palliative care is delivered (6) and where the majority of 
pharmacists are located (21). The potential for increasing involvement and developing community 
pharmacy services in this area is clear (22-33).  
 
It is important to understand how community pharmacists and their skills can be effectively 
integrated into services for the benefit of patients, their families and the MDT. Tinelli et al (35) 
identified that patients value the input of the pharmacist. They may however be resistant to changes 
in the pharmacist role, and any proposed changes will require public support. To meet patient 
requirements, pharmacists need to have good communication skills, increasing their confidence in 
delivering palliative pharmaceutical care (28, 36).  Barriers to pharmacist involvement in delivering 
palliative pharmaceutical care have been identified in several countries (36-38). In particular, 
K ?ŽŶŶŽƌ Ğƚ Ăů(39) highlight the lack of community pharmacy representation within the UK 
healthcare team, even though pharmaceutical input has previously been identified as integral to the 
multidisciplinary palliative care team.  In the UK, community pharmacists do not have easy access to 
patientƐ ? medical notes or any clinical information, which includes details of diagnosis and may be 
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unaware that a patient has palliative needs. This is a potential missed opportunity in terms of key 
aspects of care provision (40, 41). A recent joint statement from the Royal Pharmaceutical Society 
and Royal College of General Practitioners calls for closer working practices in this area, including the 
better transfer for patient information between the MDT without compromising confidentiality or 
safety (42).  
 
1.4.2 Macmillan Project Glasgow: Current Evaluation 
In 2012, the University of Strathclyde submitted an evaluation of a 2 year program of work within 
NHS Greater Glasgow & Clyde (NHS GG&C) entitled the Macmillan Pharmacist Facilitator Project 
(43). The project was located within four Community Health and Care Partnerships in the health 
board area and consisted of the University team working closely with the appointed project team to: 
deliver a baseline needs assessment report; develop a quality improvement program; prepare a 
summary document on the key activities delivered through the quality improvement program and 
synthesise a model of care with the aim of supporting  effective engagement of community 
pharmacy in the delivery of palliative care.  
 
The Glasgow project did not explore the remote and rural challenges faced by both community 
pharmacy professionals and patients/carers, which are the central tenets to the proposed service in 
NHS Highland.  
 
1.5 Macmillan Rural Palliative Care Pharmacist Practitioner Project 
The University of Strathclyde is funded to provide academic input into the NHS Highland project for 
2 years (starting February 2013). The project is to be a demonstration project to inform national 
policy and will have direct relevance to the new proposal on the delivery of pharmacy services within 
NHS Scotland,  ‘WƌĞƐĐƌŝƉƚŝŽŶ ĨŽƌ ǆĐĞůůĞŶĐĞ ? (8). This opportunity gives NHS Highland access to the 
expertise developed through the previous Glasgow program and allows the University team to 
develop the evidence base for clinical practice within this area, and focus on developing rural 
pharmaceutical care capacity through the use of a community pharmacy-based practitioner.  
 
The NHS Highland project pilots the role of one full-time Macmillan Rural Palliative Care Pharmacist 
Practitioner (referred to as Macmillan Rural Pharmacist Practitioner or MRPP) to be located within a 
community pharmacy in the Skye, Kyle & Lochalsh project area and test the ability of a community 
based pharmacist to: 
 
x Develop community pharmacy capacity to effectively, efficiently and safely support the 
needs of those in this rural community with cancer and palliative care needs regardless of 
care setting 
x Improve service provision/co-ordination of services ensuring opportunities are developed 
for training and peer support 
x Provide quality information to support practice. 
 
In response to a development request from NHS Highland, Macmillan Cancer Support agreed to fund 
an evaluation of this new model of service provision. The Boots Company PLC were awarded the 
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contract for service provision. It is intended that a positive evaluation would allow the model to be 
shared with other cancer and palliative care providers across the UK and be promoted as a model for 
use in rural areas. The aim of the evaluation is to inform the development and demonstrate the 
effectiveness of the Macmillan Rural Palliative Care Pharmacist Practitioner Project. The evaluation 
would also assess the impact of communication and co-ordination issues which relate to the 
provision of palliative pharmaceutical care to patients and carers in this rural community. 
 
The University team agreed the following aims and objectives for the evaluation with Macmillan 
Cancer Support, Boots PLC and the NHS Highland Project Steering Group.  
 
1.5.1 Evaluation Aim 
The aim of the evaluation is to inform the development, and demonstrate the effectiveness of, the 
Macmillan Rural Palliative Care Pharmacist Practitioner Project.  
 
The proposal is that a pharmacist with enhanced palliative care skills (MRPP) be based within a 
community pharmacy in the Skye, Kyle & Lochalsh area, to support service resilience and develop an 
interface role between primary and secondary care services to improve patient palliative pharmaceutical 
care. This needs a joined-up service approach and consistent service provision through implementing 
appropriate care planning models and integrating the community pharmacist into the multidisciplinary 
team.  
 
1.5.2 Evaluation Objectives 
/Ŷ ĂĚĚŝƚŝŽŶ ƚŽ ƚŚĞ ĂŝŵƐ ? ƚŚĞƌĞ ĂƌĞ ĂůƐŽ ƐƉĞĐŝĨŝĐ ŽďũĞĐƚŝǀĞƐ ĞǆƉĞĐƚĞĚ ƚŽ ďĞ ŵĞƚ ŽǀĞƌ ƚŚĞ ƉƌŽũĞĐƚ ?Ɛ
lifespan: 
x Improve the support of community pharmacy networks in relation to palliative care 
x Ensure opportunities are developed for training and peer support and provide quality 
information to support practice 
x Promote pharmacy engagement in multidisciplinary review meetings within GP practices 
x Provide relevant pharmaceutical care support for patients at home alongside the 
multidisciplinary team and voluntary agencies 
x Provide clinical pharmacy support to local community hospitals including medicines 
management advice and support at service interfaces e.g. admission, discharge to 
improve continuity of care for patients with palliative care and cancer needs 
x Provide pharmaceutical care support to care homes caring for palliative care patients.  
 
This project considers issues relating to equity of service provision within a rural area, providing 
continuity of care and access to pharmaceutical services as part of multidisciplinary care input. This 
will be regardless of the setting patients choose for care.  
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2 Phase 1: Evaluation of Current Palliative Care Pharmacy Service Provision 
2.1 Introduction 
The MRPP currently in post had previously worked as a Community Pharmacist in the project area, 
and assumed the role of MRPP from February 2013 and undertook an initial training period of 3 
months. 
 
It is anticipated a joined-up service approach and consistent service provision model can be 
implemented by using appropriate care planning models and integrating the pharmacist into the 
MDT. Additionally the issues relating to equity of service provision will be tackled regardless of which 
setting patients choose for care. However, to inform and develop the MRPP ?Ɛ role, it is necessary to 
first evaluate the current palliative care pharmacy service provision using a mixed methods 
methodology with consultation of members of the wider multidisciplinary team.  
 
This report forms the first output from the evaluation and focuses on the initial first phase 
investigation to characterise the community pharmacy service in the project area and identify 
service gaps and key issues to inform a quality improvement program.  
 
2.1.1 Study Aim 
To characterise baseline (current) pharmacy-based palliative care services in the project area, and 
identify any service gaps and key issues to inform a quality improvement program. 
 
2.2 Study Setting and Participants 
2.2.1 Setting 
This study is based the Skye, Kyle & Lochalsh area located in NHS Highland. The estimated total 
population of the project area is 13,238 (44). The Isle of Skye covers 1.6km² and has an estimated 
population density of 6 people per km² (45).  
 
Tables 1 and 2 provide an overview of the project area population, and health service provision of 
NHS Highland. It can be seen that approximately 35% of the project area population are between the 
ages of 45-64 years, and 20% are over the age of 65 years.  
 
Figure 1 presents the geography of the project area in the context of NHS Scotland.  The largest 
General Hospital in NHS Highland is Raigmore Hospital in Inverness. It is located 80 miles (1 hour 50 
minutes by car) from Kyle of Lochalsh (the most Easterly main town in the project area) and 114 
miles (2 hours 37 minutes by car) from Portree (the most Westerly main town in the project area).  
The distance between the furthest apart villages in the project area is that between Glendale (South 
of Dunvegan) and Glenelg, taking over 2 hours and covering almost 84 miles by road.   
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The greatest distance between villages in the project area is between Glendale (South of Dunvegan) 
and Glenelg, which is almost 84 miles by road and takes over 2 hours by car. The populations of the 
towns and villages in the project area are diverse. For example, Broadford Medical Practice has 
1,877 registered patients, compared wŝƚŚ'ůĞŶĞůŐ,ĞĂůƚŚĞŶƚƌĞ ?ƐƌĞŐŝƐƚĞƌĞĚƉĂƚŝĞŶƚƉŽƉƵůĂƚŝŽŶŽĨ
280 (46). 
 
 
Table 1- Population Overview Skye, Kyle & Lochalsh Project Area (2012) (46) 
 All Age 
Groups 
0-24yrs 25-44yrs 45-64yrs 65-
74yrs 
75-
84yrs 
85yrs+ 
Population (total 
number) 
13,148 3,194 2,738 4,566 1,562 746 342 
 
 
 
 
Table 2- Health Services Provision in the Skye, Kyle & Lochalsh Project Area (2013) (47, 48) 
 
 
 
 
 
 
 
 
 
 
 
                                               
1
 During the evaluation period, but after data collection, one care home closed (n=5)  
Health Services NHS Highland Skye, Kyle & Lochalsh 
Project Area 
GP practices 
 
100 7 
General Practitioners 
 
392 26 
Community Pharmacies 
 
78 3 
District Nurse Teams 
 
24 2 
Community Hospitals 
 
10 2 
Care Homes 17 61 
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Figure 1- Skye, Kyle & Lochalsh Project Area 
 
 
 
 
 
2.2.2 Study Participants 
Three separate methods were employed to provide triangulation of the findings. Participants 
included:  
 
Method 1: GPs from dispensing and non-dispensing practices, dispensing practice staff, key 
service leads (KSLs), community pharmacy staff and nursing staff 
Method 2:  Users of the Highland Hospice Phone Log (likely to include healthcare professionals, 
patients, carers and members of the public)  
Method 3: Various staff members working in the care homes in the project area.   
 
Table 3 provides details of all participants sampled in the study. The job titles of KSLs interviewed 
have been omitted to ensure anonymity.  
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Table 3- Full Participant Details  
Methods Participant by Profession (n = total number) Interviewer / Analyst 
Method 1 GP serviced by Community Pharmacy (n=1) 
Key service leads (KSL) (n=8) 
GP serviced by dispensing practice (n=2) 
Dispensing practice staff (n=1) 
Pharmacist* (n=3) 
Nurse* (n=2) 
GA 
GA/RN/EDC 
EDC/RN 
RN 
EDC 
RN 
Method 2 GP (n=8) 
Macmillan Nurse (n=2) 
Family Carer (n=1) 
Patient (n=1)* 
EDC 
EDC 
EDC 
EDC 
Method 3 Registered General Nurse (n=5) 
Social Carer (n=5) 
Carer (n=2) 
Senior Carer (n=2) 
Night Social Carer (n=2) 
Senior Social Carer (n=2) 
Manager (n=2) 
Deputy Manager (n=1) 
EDC 
EDC 
EDC 
EDC 
EDC 
EDC 
EDC 
EDC 
TOTAL Participants N= 50 NA 
*Telephone Interviews Based on Completed Logs 
**A total of 11 calls were audited, however the patient (n=1) was present during one call with GP 
 
 
2.3 Ethics 
Advice was sought by the NHS project lead from NHS Highland ?Ɛ Clinical Governance Manager and 
NHS Highland ?Ɛ Research and Development Manager as part of the North of Scotland Research 
Ethics Service.  Ethical review under the terms of the Governance Arrangements for Research Ethics 
Committees (REC) in the UK was deemed not to be required, because: 
x The project was part of a programme of service development in the area of pharmaceutical 
palliative care and it was a service which was being evaluated 
x Participant recruitment was invitational and any data would be irreversibly anonymised to 
protect identities 
x It would not be possible to identify any individual from any direct quotation used in the 
reporting of the project. 
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Furthermore, the hŶŝǀĞƌƐŝƚǇ ŽĨ ^ƚƌĂƚŚĐůǇĚĞ ?Ɛ Code of Practice on Investigations Involving Human 
Beings does not apply to work that is part of routine practices in professional contexts, a service 
evaluation or an audit of an existing service.  Consequently, ethical approval was not required for 
this piece of work.  In addition, participants were all service providers and invited by the MRPP and 
the clinical project lead.  All received a full explanation of the study and assurances about 
confidentiality and anonymity were given. 
 
 
3 Methodology 
Qualitative research aims to study, understand and represent the experiences and perspectives of 
individuals.  It plays a key role in providing insights, explanations and theories of social behaviour 
and can uncover aspects of sensitive and complex views, beliefs, attitudes and interactions.  The use 
of qualitative research methods has increased in recent years and they are now valuable tools in the 
methodological tool box of health services and pharmacy practice research. A qualitative approach 
was considered the most appropriate due to the exploratory nature of this research.   
 
This stage of the project was concerned with defining the indicators of success as well as current 
service provision.  Background discussions with the project lead highlighted areas of work upon 
which the MRPP should initially focus. This involved mapping the current service and identifying 
both strengths and gaps in the system, and allowed the University team to propose and develop a 
program of work for the MRPP over the project period which would affect current service provision.  
 
A single case study methodology, involving multiple healthcare settings within the project area was 
applied.  Various methods were used to maximise data and incorporated semi- structured interviews 
with observations (when appropriate), completion of activity logs, service audits and questionnaires.   
 
 
3.1 Method 1: Interviews, Observations & Medicine Issue Logs 
Semi-structured Interviews & Observations 
 
The MRPP made contact with the appropriate dispensing staff and GPs within all GP Practices (n=26) 
in the project area and explained the nature and requirements of the project. The names of those 
who wished to participate were communicated to a member of the University team. A sampling 
strategy was adopted, so that GPs as well as trained and untrained dispensing staff were recruited.  
Semi-structured face-to-face interviews were conducted with the focus on identifying specific 
medicine-type issues faced by the GP and the dispensing staff as well as identifying potential 
benefits provided by their service. Additionally, the researchers observed the dispensing process 
(simulated in order to protect patient identity) in dispensing practices to better understand the 
process.     
 
A number of key service leads were identified by the project steering group as being knowledgeable 
or involved in palliative care services in the project. These individuals were contacted by the MRPP 
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and the names of those who wished to participate were shared with the University team. Telephone 
or face-to-face interviews were arranged. KSLs came from a number of areas including nursing, 
general practice, home care, Scottish Ambulance Service and management.  
Interview schedules and information sheets used on these occasions can be found in Appendices 1-
4.  The interviews were digitally recorded.  Following each interview the contents of the recording 
were transcribed verbatim.  All participants were provided with an information sheet detailing the 
aims and nature of the study, and consent forms completed by those taking part. Written or verbal 
consent was given where appropriate.   
 
Basic demographic data were also collected from all interview participants excluding age and 
gender. Since the project pursues a broad approach where the profession as a group and not the 
individual is the unit of the analysis, a purposive convenience sampling strategy was employed. This 
would identify, select and recruit  those individuals who share common experiences of relevance to 
the study and who would be able to provide in-depth information about study topics (49, 50). 
Participants were also selected to gain an equal geographical and professional representation where 
possible.  
 
>ŽŐƐĞƚĂŝůŝŶŐ ?DĞĚŝĐŝŶĞƐ-Related IssueƐ ?  
 
 ĚŝĂƌǇ Žƌ  ‘log ? ŝƐconsidered an appropriate method for collecting data over an extended period. 
This was used by nursing staff and community pharmacy staff to document any pharmacy specific 
issues which may have presented during the allocated period.  The MRPP approached community 
pharmacy and nursing staff. She provided background information and raised awareness of the 
Macmillan Rural Palliative Care Pharmacist Practitioner Project. This was followed-up by a member 
of the University team who telephoned to recruit the staff into the project. 
 
Community pharmacy and nursing staff were asked to record palliative medicine issues in the log 
designed and provided by the University team.   Examples of possible palliative medicine-related 
issues were given to aide their understanding of what would be considered as an issue and to aid 
with identifying entries.  Staff were asked to complete logs over an initial 4 week period beginning 
the first week of April 2013, which was extended for a further 4 weeks due to the low volume of 
incidents.  The logs were distributed, collected and returned to the University via the MRPP. 
ŽŵŵƵŶŝƚǇƉŚĂƌŵĂĐǇƐƚĂĨĨǁĞƌĞĂƐŬĞĚƚŽŝŶĐůƵĚĞƚŚĞƉŚĂƌŵĂĐǇ ?ƐŶĂŵĞŽŶĞĂĐŚůŽŐďƵƚǁĞƌĞĂƐŬĞĚ
not to write their own names. Likewise the nurses were asked to write their team name but not their 
own name on each completed log. The logs were analysed by hand and secured in a locked cabinet 
in order to maintain participant anonymity.   
 
Once data collection ceased, completed logs were returned to the University team. Follow-up 
telephone calls were made within 8 weeks to staff by the University research team for more in-
depth discussions of issues identified in the log.  The telephone interviews were used to validate the 
logs and to provide the staff with the opportunity to freely express any further views not captured in 
the log. An example of the community pharmacy and community nursing logs can be found in 
Appendices 5-6.  
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3.2 Method 2: The Highland Hospice Phone Line Audit 
The Highland Hospice Phone Line is accessible to patients, carers and healthcare professionals as a 
source of advice (clinical and non-clinical) during and out-with office hours. All calls are logged on a 
predefined form which is completed by the hospice phone line staff, who are mixture of 
professionals and non-professionals i.e. nurses, support staff.  Recorded information consists of: 
location of the calls; nature / reason for call; and how or if the issue is resolved.  
 
An initial 8 week period was of interest but due to the low number of calls received it was extended 
to approximately 16 weeks (beginning of March until the end of June 2013).   Call details were 
analysed and if connected to palliative medicine issues, the details were extracted from the hospice 
log and entered onto a summary document supplied by the University team. The summary 
document can be found in Appendix 7.  
 
3.3 Method 3: Care Home Questionnaire 
NHS GG&C recently completed a survey of care home staff in Inverclyde.  A modified version of that 
questionnaire was used in this study of the Skye, Kyle & Lochalsh project area.   The MRPP contacted 
all care homes (n=7) and requested their participation. The MRPP distributed paper copies of a 
participant information sheet and the questionnaire to six of the seven care homes (one declined to 
participate). Copies of the Care Home Information Sheet and the Care Home Questionnaire can be 
found in Appendix 8.    
  
 
4 Results 1: Interview, Observation & Log Data Analysis 
A content analysis methodology was used to examine the interview data. Content analysis is used 
frequently in health service research (51-54). Of the three main approaches used, an inductive 
method was selected, whereby categories or codes are derived completely from the data collected 
(55). Content analysis works well in cases where little previous theory or literature is present. Since 
the aim of this research was to map current service and report it at a descriptive level, content 
analysis was deemed an appropriate approach.  
 
Three researchers contributed towards the coding of data. One interview was selected and all three 
researchers adopted a peer-to-peer consensus approach to ensure a consistent coding strategy was 
adopted. This was applied to the remaining interview data to produce the following key findings.  
Any hesitations made in the interviews have been removed and, where appropriate, words 
contained in parentheses have been added to clarify meaning or disguise any identifying 
information.  Text ƚŚĂƚ ŚĂƐ ďĞĞŶ ƌĞŵŽǀĞĚ ŝƐ ƌĞƉƌĞƐĞŶƚĞĚ ďǇ ĞůůŝƉƐĞƐ ?  dŚĞ ƉĂƌƚŝĐŝƉĂŶƚ ?Ɛ ũŽď ƚŝƚůĞ
accompanies each quote in parentheses.  
 
Below are the key findings from interviews with GPs, dispensing practice staff, nurses, Community 
Pharmacists and key service leads.  
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4.1 Setting the Scene  ? Factors Associated with the Environment and 
Infrastructure 
The project area is rural, presenting a number of challenges on a daily basis. There was a general 
ĂĐĐĞƉƚĂŶĐĞĂŵŽŶŐƉĂƌƚŝĐŝƉĂŶƚƐƚŚĂƚ ƚŚĞƌĞǁĞƌĞĨĂĐƚŽƌƐŽƵƚǁŝƚŚĂŶǇŽŶĞ ?ƐĐŽŶƚƌŽů ?regardless of the 
resources available.  
Environmental Factors 
 
The occurrence of bad weather and how this was overcome was discussed. In many instances staff 
members went out of their way to deliver services: 
 “/ŶƚŚĞǁŝŶƚĞƌǁŚĞŶƚŚĞƐŶŽǁǁĂƐƌĞĂůůǇďĂĚ ?ǇŽƵ ĐŽƵůĚŶ ?ƚŐĞƚĂƉŚĂƌŵĂĐŝƐƚĂƚƚŚĞŝƌ
premises, and one of the other pharmacists went across and worked between sort of a 
ĐŽƵƉůĞŽĨƚŚĞďƵƐŝŶĞƐƐĞƐƚŽŵĂŬĞƐƵƌĞƚŚĂƚƐĞƌǀŝĐĞƐĐŽƵůĚďĞĚĞůŝǀĞƌĞĚ ? ?ƚŚĞǇŚĂĚĂĨŽƵƌ-
by-four and took drugs out to people because tŚĞǇĐŽƵůĚŶ ?ƚŐĞƚƚŽƚŚĞŵ ? ? (KSL7) 
 
Limitations in service delivery were also posed because of the distances involved:  
 “/ƚŚŝŶŬŐĞŽŐƌĂƉŚŝĐĂůůǇǁĞ ?ƌĞĚŝƐĂĚǀĂŶƚĂŐĞĚŝŶƚŚĂƚǇŽƵŬŶŽǁ ?ǁĞĐŽǀĞƌĂŚƵŐĞ
 ?ĂƌĞĂ ? ?ŝƚ ?ƐŶŽƚůŝŬĞǁĞ ?ǀĞŐŽƚĂƉŚĂƌŵĂĐǇũƵƐƚƚǁŽŵŝŶƵƚĞƐdown the road or a doctors, 
you know, there are quite a lot of out-ůǇŝŶŐĂƌĞĂƐ ? (KSL2) 
 
The distances between the towns and villages can pose problems for healthcare professionals in 
terms of the delivery of medicines from the mainland and between locations in the project area. 
NHS Highland (and the project area) is large geographically, yet it represents a cohort of patients 
relatively small in number for its size.  One participant commented on the dispersion of population 
using Glasgow and Edinburgh as examples to demonstrate the distances: 
 “zŽƵĐŽƵůĚĨŝƚ'ůĂƐŐŽǁZŽǇĂůŝŶĨŝƌŵĂƌǇĂŶĚĚŝŶďƵƌŐŚZŽǇĂů/ŶĨŝƌŵĂƌǇďŽƚŚŝŶƚŽ^ŬǇĞĂŶĚ
>ŽĐŚĂůƐŚ ?zŽƵŬŶŽǁƚŚĞǇ ?ƌĞŽŶůǇƚŚŝƌƚǇĨŝǀĞŵŝůĞƐĂƉƌƚďƵƚŽƵƌƉĞŽƉůĞĂƌĞƐƉƌĞĂĚŽƵƚĂůů
ŽǀĞƌƚŚĞƉůĂĐĞ ? (KSL6) 
 
Given the small general population in the area, participants commented on how infrequently they 
see or treat patients with palliative needs. This can make some professionals feel de-skilled in 
dealing with palliative care medicines. It is likely that building up experience within the speciality will 
take longer than in an urban area:  
 “Ƶƚ/ŚĂǀĞŶ ?ƚŐŽƚƚŚŝƐŚƵŐĞĞǆƉĞƌŝĞŶĐĞŽĨǇĞĂƌƐ ?ĂŶĚǇĞĂƌƐ ?ǁŽƌŬŝŶŐŝŶƚŚŝƐĨŝĞůĚǁŝƚŚĂ
ǁŚŽůĞƉůĞƚŚŽƌĂŽĨƐƚŽƌŝĞƐ ?ǇŽƵŬŶŽǁ ?ĂŶĞĐĚŽƚĂůƐƚŽƌŝĞƐ ?/ĚŽŶ ?ƚŚĂǀĞƚŚĂƚ/ ?ŵĂĨƌĂŝĚ ? ? 
(KSL2) 
 
One overriding characteristic that emerged was the strong sense of community spirit. Most 
participants commented on how close residents were to one another, despite the geographical 
ĚŝƐƚĂŶĐĞƐŝŶǀŽůǀĞĚ ?ĂŶĚŚŽǁĞǀĞƌǇŽŶĞ ?ƐŝŶƐƚŝŶĐƚǁĂƐƚŽŚĞůƉŽƵƚas much as possible: 
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 “dŚĂƚŵĂŬĞƐŵĞƚŚŝŶŬƚŚĂƚƚŚĞƉĂƚŝĞŶƚĂĐƚƵĂůůǇŐĞƚƐĂďĞƚƚĞƌĚĞĂůƵƉŚĞƌĞ ?ďĞĐĂƵƐĞƚŚĞǇ
ŐĞƚĚĞĂůƚǁŝƚŚďǇƐŽŵĞďŽĚǇƚŚĂƚƚŚĞǇŬŶŽǁ ? ?(GP from a Dispensing Practice) 
 
This ethos was also fostered from a clinical perspective. Healthcare professionals are seen to go 
 “ĂďŽǀĞĂŶĚďĞǇŽŶĚ ?ƚŽŵĂŬĞƐƵƌĞƚŚĂƚƚŚĞƉĂƚŝĞŶƚƌĞĐĞŝǀĞƐƚŚĞĂƉƉƌŽƉƌŝĂƚĞƚƌĞĂƚŵĞŶƚ ?ƉĂƌƚŝĐƵůĂƌůǇ
as the prompt supply of some medicines, e.g.  specials or specific formulations cannot be as timely 
as desired. Furthermore, during the out-of-hours period getting the right medicines to patients 
following recognised procedures/ channels can also be challenging.  However, every effort is made 
to ensure that the patient is not left without treatment: 
 
 “KďǀŝŽƵƐůǇǁŚĞŶŝƚ ?ƐƚŽĚŽǁŝƚŚŽŶĞŽĨ ?ƚŚĞƉĂůůŝĂƚŝǀĞ ?ƉĂƚŝĞŶƚƐǇŽƵĚŽĂůůǇŽƵĐĂŶ ? ? (Pharmacist) 
 
 “/ŵĞĂŶƚŚĞƉƌŽďůĞŵŝƐ ?ŝƐƚŚĞƌĞĂůŝƚǇŽĨĐůŝŶŝĐĂůƉƌĂĐƚŝĐĞĂƚ ?Ž ?ĐůŽĐŬŝŶƚŚĞŵŽƌŶŝŶŐĂŶĚƚŚĞ
ƌĞĂůŝƚǇŽĨƉĞŽƉůĞǁŚŽŵĂŬĞƌƵůĞƐ ?ƚŚĞǇĚŽŶ ?ƚĐŽŝŶĐŝĚĞ ?ǇĞĂŚ ?zŽƵŐĞƚƌŽƵŶĚŝƚďǇ
documentinŐŝƚƐŽŚŽƉĞĨƵůůǇ ?ǇŽƵĐĂŶĚĞŵŽŶƐƚƌĂƚĞƚŚĂƚŝƚǁĂƐĂůůĚŽŶĞŝŶƉĞƌŚĂƉƐŶŽƚƚŽ
ƚŚĞƌƵůĞďƵƚĐĞƌƚĂŝŶůǇƚŽƚŚĞƐƉŝƌŝƚŽĨƚŚŝŶŐƐ ? ?(KSL6) 
 
Infrastructural Factors 
Internet connection and mobile telephone reception was found to be unreliable. Furthermore, some 
particularly isolated parts of the project area completely lacked telephone reception:  
 “DŽďŝůĞƉŚŽŶĞƌĞĐĞƉƚŝŽŶŝƐƉŽƐƐŝďůĞŝĨǇŽƵ ?ƌĞƐƚĂŶĚŝŶŐŽŶƚŚĞďĞĂĐŚĂŶĚŽŶĐĞǇŽƵƚƵƌŶ
ĂǁĂǇĨƌŽŵƚŚĞďĞĂĐŚǇŽƵ ?ǀĞŚĂĚŝƚ ?(GP from Dispensing Practice) 
Although this could be considered challenging, most people had access to landline telephones. 
Furthermore, one participant reported that not having had regular access to mobile phone reception 
over the years has resulted in a lack of reliance on it, therefore other means were often deployed 
when attempting to contact patients or other healthcare professionals.  
Other travel issues were also faced on a daily basis, including the lack of public transport in 
particularly rural areas, and the sometimes dangerous single-track roads: 
 
 “dŚĞƌĞĂƌĞĂŶƵŵďĞƌŽĨĞůĚĞƌůǇƉĞŽƉůĞ ?ůŝǀŝŶŐŚĞƌĞ ? ?ƐŽ/ŬŶŽǁƚŚĞƌĞ ?ƐŶŽƉƵďůŝĐƚƌĂŶƐƉŽƌƚ
ƚŚĞƌĞƵŶůĞƐƐƚŚĞǇƌŝŶŐƵƉĂŶĚŽƌĚĞƌƚŚĞďƵƐ ? (GP from Dispensing Practice) 
 “/ƚ ?ƐĂƌĞĂůůǇďĂĚƌŽĂĚ ?ĂŶĚƚŚĞƌŽĂĚĨƌŽŵŚĞƌĞƚŽ ?ǀŝůůĂŐĞ ?ŝƐƋƵŝte good but then [the road] 
is really bad, single track, you know, pretty dodgy, so it could take you forty five minutes to 
ǇŽƵŬŶŽǁ ?ĂŶŚŽƵƌ ? ? (KSL2) 
 
Although there are a wide range of environmental and infrastructure factors affecting the project 
area those interviewed seemed to foster an adaptive and flexible attitude towards such challenges.   
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4.2 Setting the Scene- Pharmacy Service Provision 
Details of the current pharmacy service in relation to palliative care identified the following.    
 
4.2.1 Level of Service 
Participants described the current service provision within and outwith working hours. Healthcare 
professionals made reference to a number of healthcare professionals or resources that they relied 
on in an out-of-hours situation, including NHS 24, local Community hospitals and GPs. GPs from the 
dispensing practices mentioned that rather than their palliative patients contacting NHS 24 in the 
evenings or weekends, they preferred their patients to contact the GP at home via a specific surgery 
number or to contact the local Community Hospitals.  NHS 24 was not seen as an ideal resource for 
their patients.  
 “ŶĚƐŽĂƚƚŚĞǁĞĞŬĞŶĚƐŽƌŽǀĞƌŶŝŐŚƚ ?ŝĨŝƚǁĂƐĂƋƵĞƌǇďĞĨŽƌĞ ? ?Ž ?ĐůŽĐŬƚŚĞŶǁĞ ?ĚƐĂǇ
ƉŚŽŶĞWŽƌƚƌĞĞŚŽƐƉŝƚĂů ?ŝĨŝƚ ?ƐĂŶŽǀĞƌŶŝŐŚƚƋƵĞƌǇũƵƐƚƉŚŽŶĞ ƌŽĂĚĨŽƌĚĂŶĚǁĞ ?ůůŐŝǀĞƚŚĞŵ
ƚŚĞƚĞůĞƉŚŽŶĞŶƵŵďĞƌƐŽƚŚĞǇĚŽŶ ?ƚŚĂǀĞƚŽŐŽƚŚƌŽƵŐŚƚŚĞƉĂŝŶŽĨƉŚŽŶŝŶŐE,^ ? ? ? ? (GP 
from a Dispensing Practice) 
Participants all provided examples of who they would contact and how during out-of-hours periods. 
Managing resources and staff members to allow patients to die in the location of their choosing can 
be difficult due to the geography involved. The current Marie Curie contribution is helpful but it is 
acknowledged that due to the rural nature of the area, they often face difficulties with recruitment 
of staff: 
 “dŚĞƉƌŽďůĞŵǁŝƚŚƚŚĞƌƵƌĂůĂƌĞĂŝƐƚŚĂƚŝĨƉĞŽƉůĞǁĂŶƚƚŽĚŝĞĂƚŚŽŵĞ ?ǁĞ ?ƌĞŶŽƚǁĞůů
ƌĞƐŽƵƌĐĞĚ ?ǁĞŚĂǀĞƚŽŬŝŶĚŽĨƚŚŝŶŬŽĨǁĂǇƐƌŽƵŶĚƚŚŝŶŐƐĂŶĚƚƌǇĂŶĚŐĞƚƐƚĂĨĨƚŽ
ŚĞůƉ ?ǁĞŶĞĞĚƚŚĞŽǀĞƌ-night care so that famŝůŝĞƐĐĂŶŐĞƚĂƐůĞĞƉ ?ƐŽǁĞ ?ƌĞŶŽƚǁĞůů
ƌĞƐŽƵƌĐĞĚǁŝƚŚƌĞŐĂƌĚƚŽ ?DĂƌŝĞƵƌŝĞ ?ďŽĚŝĞƐŽŶƚŚĞŐƌŽƵŶĚ ? (KSL1) 
 
Nurses in the community hospitals were found to be responsible for ordering medication (stock or 
otherwise). It would appear that pharmacy support in this area, including the provision of advice and 
information would go some way in improving the current service.  
 
4.2.2 Local and National Networks 
The local GPs, care home staff and community pharmacies were all seen as vital in the delivery of 
care for their patients.   GP surgeries, medical centres, care homes, Raigmore Hospital and the 
Highland Hospice, both based in Inverness, were also mentioned by participants as sources of 
information/support. Other resources further afield included: NHS 24 Phone Service, the Scottish 
Government, and hospitals based in Aberdeen, Glasgow & Edinburgh.  
The project area includes four dispensing practices which provide medicines where there are no 
community pharmacies.  Dispensing practices are responsible for their own stock ordering and 
provision.  However, they too like community pharmacies can experience difficulties in ordering 
ĐĞƌƚĂŝŶŵĞĚŝĐŝŶĞƐ ?WĂƚŝĞŶƚƐĂƌĞĨƵƌƚŚĞƌĚŝƐĂĚǀĂŶƚĂŐĞĚĂƐƚŚĞǇǁŝůůďĞƵŶĂďůĞƚŽ ‘ƐŚŽƉĂƌŽƵŶĚ ?ǁŝƚŚ
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their prescription and get it dispensed elsewhere given the lack of community pharmacies. This 
suggests that a more formalised link with community pharmacy may be required to provide a 
practical solution to supply issues.  
Participants referred to a wide range of disciplines that they interacted with in providing care.  These 
include: podiatrists, dieticians, physiotherapists, a local handyman (employed by the council and 
NHS), hospital clinicians, nurses, the Care At Home Officer, occupational therapists, rural 
practitioners, social workers, cancer specialist, Marie Curie nurses, and nurse specialists. Formal 
discussions were routinely held, such as Gold Standards Framework meetings, where the MDT meet 
ƚŽĚŝƐĐƵƐƐŝŶĚŝǀŝĚƵĂůƉĂƚŝĞŶƚƐ ?ĐƵƌƌĞnt needs.  Discussions amongst professionals and the wider team 
also occurred on an ad-hoc basis by telephone or face-to-face: 
 “/ƚǁĂƐŶ ?ƚĚŽĐƵŵĞŶƚĞĚĂƐĂŐŽůĚƐƚĂŶĚĂƌĚƐĨƌĂŵĞǁŽƌŬŵĞĞƚŝŶŐ ?ƚŚĞŝƐƚƌŝĐƚEƵƌƐĞǁŽƵůĚ
call in-  “ŽŚ/ ?ǀĞũƵƐƚƐĞĞŶƐŽĂŶĚƐŽ ? ?ĂŶĚǁĞ ?ĚŚĂǀĞĂƚĂůŬĂďŽƵƚŝƚƐŽŝƚǁĂƐĂůŽƚŵŽƌĞƐŽƌƚ
ŽĨŝŶĨŽƌŵĂů ? ?'WĨƌŽŵŝƐƉĞŶƐŝŶŐWƌĂĐƚŝĐĞ ? 
Nurses, GPs and other professionals also engage in regular telephone calls. Some participants 
reported that communication was variable with professionals outside of the project area, but given 
the small number of professionals in the project area, it was easier for relationships to develop and 
it is often this familiarity which facilitates effective communication: 
 
 “tĞŵŝŐŚƚĨŝŶĚŽƵƚƚŚĂƚƐŽŵĞďŽĚǇ ?ƐďĞĞŶĂĚŵŝƚƚĞĚƚŽŚŽƐƉŝƚĂůďĞĐĂƵƐĞĞǀĞƌǇĚĂǇǁĞ
communicate with the hospital at half past one, everyone in social work and that, we 
have a teleconference so that we discuss clients wŚŽ ?ǀĞďĞĞŶĂĚŵŝƚƚĞĚĂŶĚƚŚĞŶǁĞ
have discharge meetings on a Tuesday and we have a care plan meeting every 
dŚƵƌƐĚĂǇ ?ƐŽƚŚĂƚƉĞŽƉůĞĂƌĞŝŶƚŚĞůŽŽƉ ? ? (KSL2) 
 
Various examples were given of good MDT interaction resulting in better care. This would be 
particularly successful when the professional involved not only had a good understanding of 
palliative care, but also the local geography and the service, including inevitably its limitations.  One 
participant described a situation where a patient in hospital in Inverness wished to die at home in 
Skye, and the positive and negative aspects of this transfer: 
 
 “/ƚŚŝŶŬ ?ƐƚĂĨĨĂƚŚŽƐƉŝƚĂůŝŶ/ŶǀĞƌŶĞƐƐ ?ƐŽƌƚŽĨǁŽƌŬĞĚƌĞĂůůǇǁĞůůĂƚƚŚĞŝƌĞŶĚ ?ƚŚĞǇǁĞƌĞ
able to let us know and get all the stuff together so they came out and gave us enough 
ǁĂƌŶŝŶŐƚŽŐĞƚĞǀĞƌǇƚŚŝŶŐŝŶƉůĂĐĞŝŶƚŚĞŚŽƵƐĞ ?/ŵĞĂŶŝƚƚĂŬĞƐĐŽŽƉĞƌĂƚŝŽŶ ?ƉŚŽŶĞĐĂůůƐ
ĂŶĚƚŚŽƵŐŚƚĨƌŽŵƉĞŽƉůĞ ?/ĨƚŚĞǇŚĂĚŶ ?ƚǁĂƌŶĞĚƵƐƚŚĂƚŚĞǁĂƐĐŽŵŝŶŐŚŽŵĞ ?ǁŽƵůĚ
ƌĞƋƵŝƌĞƐǇƌŝŶŐĞĚƌŝǀĞƌ ?/ǁŽƵůĚŶ ?ƚŚĂǀĞďĞĞŶĂďůĞƚŽŐĞƚĂŚŽůĚŽf the District Nurse to get 
ƚŚĞƐǇƌŝŶŐĞĚƌŝǀĞƌŽǀĞƌ ?ƐŽĐŽŽƉĞƌĂƚŝŽŶĂŶĚƚŚŽƵŐŚƚǀĞƌǇŵƵĐŚƌĞƋƵŝƌĞĚ ? ?(GP from 
Dispensing Practice) 
 
This demonstrates local understanding of how services, including pharmacy services operate. 
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4.3 Current Strengths of the Service 
4.3.1 Healthcare Professionals Planning 
A degree of pre-planning was evident.  One KSL described how care home staff would check any new 
item prescribed for a resident against a list of stock carried by the local community pharmacy before 
sending a member of staff to collect once dispensed. This was to avoid unnecessary delays in the 
event that an item may not be in stock:  
 
 “tŚĞŶƚŚĞĚŽĐƚŽƌƐĂƌĞƉƌĞƐĐƌŝďŝŶŐǁĞƚĞŶĚƚŽƌŝŶŐ ?ƚŚĞƉŚĂƌŵĂĐǇ ?ƚŽƐĞĞǁŚĂƚƚŚĞǇ ?ǀĞŐŽƚ
in- ŝŶĐĂƐĞƚŚĞǇ ?ƌĞǁƌŝƚŝŶŐĨŽƌŝĂŵŽƌƉŚŝŶĞ  ? ?ŵŐ ?/ĨƚŚĞǇ ?ǀĞŽŶůǇŐŽƚ ?ŵŐŝŶ ?ǁĞ ?ůůŐĞƚƚŚĞ
ĚŽĐƚŽƌƚŽǁƌŝƚĞŝƚŽƵƚĨŽƌ ?ŵŐ ? ?ǀŝĂůƐ ?^ŽǁĞƚĞŶĚƚŽĐŚĞĐŬǁŚĂƚƚŚĞǇ ?ǀĞŐŽƚŝŶĨŝƌƐƚ ?ƐŽƚŚĂƚ
ǁĞŬŶŽǁƚŚĂƚǁĞĐĂŶŐĞƚŝƚ ? ‘ĐĂƵƐĞƐŽŵĞƚŝŵĞƐŝƚĐĂŶƚĂŬĞĂĨĞǁĚĂǇƐ ? ?(KSL3) 
The community pharmacies supply medicines for prescriptions from GP surgeries and care homes in 
the area. Dispensing practices order their own stock whilst the community hospitals access their 
medicines as stock from Raigmore Hospital.  Most participants gave details on informal methods of 
addressing medicines issues in more challenging times or when a specialist medicine was needed. 
The local pharmacies also stock medicines as per the palliative care core drugs list, but some 
examples were given where doses of certain drugs were prescribed that did not comply with the 
palliative care core drugs list and hence caused problems with supply: 
 “dŚĞĨŝƌƐƚƐĐƌŝƉƚƚŚĂƚĐĂŵĞŝŶĨŽƌƚŚĞŵŝĚĂǌŽůĂŵ ?ǁĞŚĂĚƚŚĞ ?ŵůŽŶĞĂŶĚĂĐƚƵĂůůǇƚŚĞ
doctor wanted the 5ml [ampule] so actually we had to go back and just get the doctor to 
ĐŚĂŶŐĞŝƚƚŽƚŚĞ ?ŵůƐŝǌĞ ?ĂŵƉƵůĞ ? ?ƚŚĞĚŽĐƚŽƌŚĂĚŶ ?ƚƌĞĂůŝƐĞĚƚŚĂƚƚŚĞƌĞ ?ƐƚŚĞ ?ŵů
strength we would always have in stock but anyway that wasn't a problem, we just went 
up to the surgery and got him to change it and then sent out the 2ml ŽŶĞ ?ůƵĐŬŝůǇǁĞ
ŚĂǀĞƚŚĞƐƵƌŐĞƌǇƐŽŶĞĂƌƚŽƵƐ ?ƚŚĞĚŽĐƚŽƌũƵƐƚǁƌŽƚĞƚŚĞŶĞǁƐĐƌŝƉƚŽƵƚƚŚĞƌĞĂŶĚƚŚĞŶ
and then we were able to dispense it. ? ?WŚĂƌŵĂĐŝƐƚ ? 
 
The use of Just In Case boxes (JIC) was well documented. These boxes can be distributed to patients 
with palliative needs and contain small amounts of essential medicines in the event that access to 
medicines or a healthcare professional is not possible, particularly during out-of-hours periods or 
during periods of bad weather.  Many professional interviewed welcomed the use of these boxes, 
stating that they had been adopted and used well, and that it was helpful to know that a patient was 
not without an essential medicine.  
 
4.3.2 Equipment & Medicines 
Some participants talked about the availability of syringe pumps/drivers. There are a limited number 
of these spread over a large geographical area, however, given the generally low incidence of 
palliative care patients it can result in low demand for them and other specialist equipment: 
 ?/ƚŚŝŶŬǁĞ ?ǀĞŽŶůǇĞǀĞƌŚĂĚŽŶĞĞƉŝƐŽĚĞǁŚĞƌĞǁĞ ?ǀĞŚĂĚƚǁŽƉĞŽƉůĞŽŶƐǇƌŝŶŐĞĚƌŝǀĞƌƐĂŶĚ
ƚŚĞĐŽŵŵƵŶŝƚǇǁŝůůůŽĂŶƵƐŽŶĞŽĨƚŚĞŝƌƐŝĨƚŚĞǇ ?ƌĞŶŽƚŝŶƵƐĞƐŽŝƚ ?ƐƋƵŝƚĞŐŽŽĚůŝŬĞƚŚĂƚ ? ? 
(KSL3) 
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Overall, participants were generally happy and perceived a good service for accessing medicines. 
Different strategies appear to be employed by e.g. prescribing an alternative medicine or avoiding a 
medicines altogether but appeared to generally cope very well in most situations. Furthermore, 
communications between, for example, dispensing practice and pharmacies mean that efforts are 
always made to source something locally before ordering it specifically from further afield: 
 ?/ ?ůůƉŚŽŶĞ ?ƚŚĞƉŚĂƌŵĂĐǇ ? ?ŝĨǁĞŚĂǀĞŶ ?ƚŐŽƚƐƵĐŚ-and-ƐƵĐŚ ? “ĂŶǇŽƵŐĞƚŝƚ ? ? ?ƐŽŵĞƚŝŵĞƐ
ǇŽƵŬŶŽǁƐƚƵĨĨ ?ƐŽƵƚŽĨƐƚŽĐŬĂƚůůŝĂŶĐĞ,ĞĂůƚŚĐĂƌĞ ?/ ?ůůƉŚŽŶĞƵƉ ?ƚŚĞƉŚĂƌŵĂĐǇ ?- “ŚĂǀĞ
ǇŽƵŐŽƚŝƚ ?ĐĂŶǇŽƵŐĞƚŚŽůĚŽĨŝƚ ? ?ĐĂƵƐĞƚŚĞǇƵƐĞĂĚŝĨĨĞƌĞŶƚǁŚŽůĞƐĂůĞƌ ? ? ?'WĨƌŽŵ
Dispensing Practice) 
 
Specials2 (particularly solutions) were seen as the most difficult items to supply. The majority are 
especially extemporaneously prepared from a specific manufacturer or hospital production unit, and 
ordering and supply can take time.  Any delay can be further exacerbated due to remoteness and 
distance. Delay is caused further by some of the authorisation processes demanded by the Health 
Board.   However, the situation can be managed if the patient is kept informed: 
 “ ?hŶůŝĐĞŶƐĞĚƐƉĞĐŝĂůƐ ?ĚŽƚĂŬĞĂďŝƚůŽŶŐĞƌĂŶĚƚŚĞƐŽƌƚŽĨƐƚƌĂŝŐŚƚĨŽƌǁĂƌĚƐƉĞĐŝĂůƐĂůƐŽ
take longer than our normal ŽƌĚĞƌ ?ǁĞĚŽŚĂǀĞƚŽĂŶĚǁĞĚŽƚƌǇĂŶĚŵĂŬĞƉĂƚŝĞŶƚƐ
ĂǁĂƌĞŝĨƚŚĞǇĂƌĞŐŽŝŶŐƚŽďĞƚĂŬŝŶŐůŽŶŐĞƌ ? ?(Pharmacist) 
  
 
4.3.3 Continuity of Care 
There appears to be a high level of continuity of care, perhaps as a consequence of the close-knit 
nature of the community and the small numbers of staff involved: 
 “dŚĞďŝŐƐƚƌĞŶŐƚŚŝƐƚŚĂƚǁĞ ?ƌĞƐƚŝůůĂĐŽŵŵƵŶŝƚǇ ?zŽƵŬŶŽǁ ?ƉĞŽƉůĞĂƌĞƐƚŝůůůŽŽŬŝŶŐĂĨƚĞƌ
one another,  you know nurses and doctors  are part of the community and looking after 
ƉĞŽƉůĞǁŚŽĂƌĞƚŚĞŝƌŶĞŝŐŚďŽƵƌƐ ?ďĞĐĂƵƐĞǁĞ ?ƌĞĂƐŵĂůůƐĞƌǀŝĐĞ ?ǇŽƵ ?ƌĞůŽŽŬĞĚĂĨƚĞƌďǇ
ƚŚĞƐĂŵĞŶƵƌƐĞƐǁŚĞŶǇŽƵ ?ƌĞŝůůŐĞƚƚŝŶŐĐŚĞŵŽŽƌǁŚĞŶǇŽƵ ?ƌĞƚĞƌŵŝŶĂůůǇŝůůƐŽƚŚĂƚ ?ƐĂ
ŐƌĞĂƚƐƚƌĞŶŐƚŚŽĨŽƵƌƐĞƌǀŝĐĞ ? ?(KSL6) 
 
Furthermore, since there is less demand on palliative services than in an urbĂŶ ƐĞƚƚŝŶŐ ? ĚŽĐƚŽƌƐ ?
appointments and meetings with nursing staff tend to be less time-dependent. As they have smaller 
case-loads, healthcare professionals can spend time becoming ŵŽƌĞĨĂŵŝůŝĂƌǁŝƚŚƉĂƚŝĞŶƚƐ ?ƉƌŽďůĞŵƐ
and needs, and care can be better tailored: 
 “/ĨĂĂƌĞƚ,ŽŵĞ [staff member] is going in to see somebody a couple of times a day, 
ƚŚĞǇĐĂŶƉŝĐŬƵƉŽŶǁŚĞƚŚĞƌƐŽŵĞďŽĚǇ ?ƐĞĂƚŝŶŐ ?ĚƌŝŶŬŝŶŐ ?ůŽŽŬŝŶŐƵŶŬĞŵƉƚ ?ĂůůŽĨ
ƚŚŽƐĞůŝƚƚůĞ ?ƐƵďƚůĞƚŚŝŶŐƐƚŚĂƚǇŽƵĐĂŶ ?ƚƌĞĂůůǇŐĞƚŝŶĂƚĞŶŵŝŶƵƚĞĚŽĐƚŽƌ ?ƐĂƉƉŽŝŶƚŵĞŶƚ ?
^ŽƚŚĞǇ ?ǀĞŐŽƚĂŶŽǀĞƌĂůůƉŝĐƚƵƌĞŽĨŚŽǁƚŚĂƚƉĞƌƐŽŶůŝǀĞƐĂŶĚǁŚĂƚ ?ƐŶŽƌŵĂůĨŽƌƚŚĂƚ
ƉĞƌƐŽŶĂŶĚǁŚĂƚ ?ƐĂĐŚĂŶŐĞĨŽƌƚŚĂƚƉĞƌƐŽŶ ?tĞŚĂǀĞŵĞĞƚŝŶŐƐǁŝƚŚƚŚĞŶƵƌƐĞƐ
                                               
2
 Products which are unlicensed and are specifically prescribed for an individual. A pharmaceutical special is a 
medicine made to satisfy an individual patient need. 
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regularly, we have doctors meetings  W they can feed that back to their colleague who 
work back-to-back with them and see if ƚŚĞǇ ?ǀĞŶŽƚŝĐĞĚĂŶǇƚŚŝŶŐ ?ŝƚŵŝŐŚƚƉƌĞǀĞŶƚĂŶ
ĂĐƵƚĞĞƉŝƐŽĚĞ ? ?(KSL2) 
 
4.4 Current Gaps in the Service 
4.4.1 Healthcare Professional Educational Needs 
 Existing Education 
Participants mentioned various existing educational opportunities relating to palliative care that they 
had received, such as using syringe pumps, as well as more general training on palliative care 
pharmacy. There was also some indication that healthcare professionals could request to attend 
specific courses if there was an apparent need, and an online learning system was also mentioned: 
 ?tĞ ?ǀĞŐŽƚǀĂƌŝŽƵƐƉĂůůŝĂƚŝǀĞĐĂƌĞƚƌĂŝŶŝŶŐǀŝĂ>ĞĂƌŶƉƌŽ ?ǁŚŝĐŚĂůůŽĨŽƵƌŶƵƌƐĞƐĂƌĞ
ƐƚƌŽŶŐůǇĂĚǀŝƐĞĚƚŽƵŶĚĞƌƚĂŬĞ ?ŝƚis part of their PDPs 3and EKSF4Ɛ ?ƐŽƚŚĂƚ ?ƐĐĞƌƚĂŝŶůǇĂ
number of modules on that, that people are advised to undertake. ..we have had training 
ĨƌŽŵƚŚĞŚŽƐƉŝĐĞŝŶǀĂƌŝŽƵƐĂƌĞĂƐĂƌŽƵŶĚƉĂůůŝĂƚŝǀĞĐĂƌĞ ?ĂŶĚǁĞ ?ǀĞŶŽǁƐĞƚƵƉĂ
quarterly prescribing forum loĐĂůůǇĂƐǁĞůů ?ƚŚĞǇ ?ƌĞŽďǀŝŽƵƐůǇŬĞĞŶƚŽŚĂǀĞƚŚĂƚĨŽƌƵŵ
ŐŽŝŶŐƐŽƚŚĞǇ ?ƌĞŬĞĞƉŝŶŐƵƉƚŽƐƉĞĞĚ ? ? (KSL5) 
 
Online distance learning is suitable for a remote community provided that there is a reliable internet 
connection for users. Furthermore, the emphasis on training courses as part of official educational 
requirements such as Knowledge and Skills Framework and Continued Professional Development 
ensures that healthcare professionals are making a conscious effort to develop their skills. Finally, it 
was encouraging to see an emphasis on updating and refreshing current skills, particularly due to the 
low number of palliative care patients. The lack of practical experience with dealing with palliative 
patients is somewhat substituted with regular refresher courses and educational experiences.  
 Perceived Gaps 
There was a general consensus of a need for greater awareness of medicines routinely used in 
palliative care and how they are used. Particular issues around the legislation for prescriptions for 
controlled drugs were identified:  
 “^ŽŵĞ'WƐŵĂǇďĞũƵƐƚĚŽŶ ?ƚƋƵŝƚĞƵŶĚĞƌƐƚĂŶĚĂďŽƵƚƚŚĞǁƌŝƚŝŶŐŽĨƚŚĞƉƌĞƐĐƌŝƉƚŝŽŶ ?ŝƚ
did happen last week funnily enough and the pharmacist returned it to the doctor 
ďĞĐĂƵƐĞŝƚǁĂƐŶ ?ƚǁƌŝƚƚĞŶƉƌŽƉĞƌůǇĂŶĚƚŚĂƚĚŽĞƐĐĂƵƐĞĚĞůĂǇƐ ?ƚŚĞǇ ?ƌĞŶŽƚŵĂǇďĞŚĂŶĚ-
ǁƌŝƚŝŶŐƉƌĞƐĐƌŝƉƚŝŽŶƐĨŽƌĐŽŶƚƌŽůůĞĚŵĞĚŝĐŝŶĞƐĂůŽƚ ? ?(KSL4) 
 
Training needs for the whole pharmacy team, including support and counter staff, on various aspects 
of pharmaceutical palliative care were identified. This included raising awareness of treatment 
options and alternative formulations so that pharmacy staff feel empowered to deal with situations 
                                               
3
 PDP- Professional Development Plans 
4
 EKSF- Electronic Knowledge and Skills Framework 
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when a medicine is not accessible or effective. A situation was described whereby a medicine had 
been prescribed but was unavailable and was ordered. However, another medication could have 
been used with equal effect. This suggests that information about different drugs, formulations and 
alternatives needs to be more widely disseminated to avoid delays in service provision.  
The GP was seen as the main authority on medicines information and in the delivery of palliative 
care. The interview data showed a great dependence on GPs with little input from pharmacy at 
either a clinical or basic supply level. Some healthcare professionals also commented that GPs are 
sometimes reluctant to place patients on the palliative care register until the final few months or 
weeks ŽĨůŝĨĞ ?ƉĞƌŚĂƉƐŝŶĚŝĐĂƚŝŶŐĂůĂĐŬŽĨƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨƚŚĞƚĞƌŵ ‘ƉĂůůŝĂƚŝǀĞ ? P
  “/ƚŚŝŶŬŐĞŶĞƌĂůůǇƚŚĞĚŝĨĨŝĐƵůƚǇŝŶƌĞĐŽŐŶŝƐŝŶŐwhat is palliative care is the single biggest 
ĐŚĂůůĞŶŐĞ ?ďĞĐĂƵƐĞǁĞŬŶŽǁƚŚĂƚ'WƐƐƚƌƵŐŐůĞǁŝƚŚŝƚďĞĐĂƵƐĞƚŚĞǇĚŽŶ ?ƚƌĞĐŽŐŶŝƐĞǁŚĞŶ
to put people on the palliative care register, what does being palliative care mean?... you 
know that actually some of these principles and processes are really, really key and it 
ŵĂŬĞƐƐƵĐŚĂĚŝĨĨĞƌĞŶĐĞƚŽƚŚĞƉĂƚŝĞŶƚ ? ?(KSL7) 
 
Perhaps the reluctance to place people on the palliative care register is a fear or aversion regarding 
ǁŚĂƚ ůĂďĞůůŝŶŐ ƐŽŵĞŽŶĞ ĂƐ  ‘palliative ? might mean for the patient. Comments were made by 
participants around the close-knit nature of the community and that everyone finds out about each 
ŽƚŚĞƌ ?ƐƉĞƌƐŽŶĂůĐŝƌĐƵŵƐƚĂŶĐĞƐ P 
  “But you know up here patient confidentiality is very important for us any way in the 
ĂŵďƵůĂŶĐĞƐĞƌǀŝĐĞ ?ďƵƚƵƉŚĞƌĞǇŽƵŚĂǀĞƚŽďĞŵƵĐŚŵŽƌĞůĞƚ ?ƐƐĂǇĂǁĂƌĞŽĨŝƚĂŶĚ
ĐŽƵŶƚĞƌĂĐƚŝƚĂƐǁĞůů ?ĞĐĂƵƐĞƉĞŽƉůĞďǇŶĂƚƵƌĞ ?ĞƐƉĞĐŝĂůůǇƵƉŚĞƌĞƚŚĞǇ ?ƌĞŝŶƋƵŝƐŝƚŝǀĞ ? ? 
(KSL8) 
 
The two dispensing practices which were involved in the evaluation identified some service gaps.  
Caution was raised regarding comparison of dispensing services with formal pharmacy services: 
 “ ‘ĂƵƐĞƚŚĞ'WƐƉĞƌĐĞƉƚŝŽŶŝƐƚŚĂƚƚŚĞǇ ?ƌĞƉƌŽǀŝĚŝŶŐƉŚĂƌŵĂĐĞƵƚŝĐĂůƐĞƌǀŝĐĞƐ ?ďƵƚƚŚĞǇ ?ƌĞ
ŶŽƚ ?ƚŚĞǇ ?ƌĞƉƌŽǀŝĚŝŶŐĚŝƐƉĞŶƐŝŶŐƐĞƌvices if they looked at the definitions under the 
ůĂǁ ?ƚŚĞƌĞŝƐŶ ?ƚĂƉŚĂƌŵĂĐŝƐƚƚŚĞƌĞƚŽŽǀĞƌƐĞĞ ?ĂŶĚƐŽŵĞŽĨƚŚĞĚŝƐƉĞŶƐĞƌƐĂƌĞŶŽƚ
ƚƌĂŝŶĞĚŽƚŚĞƌƚŚĂŶďǇƚŚĞ'WƐƚŚĞŵƐĞůǀĞƐ ? ?(KSL7) 
 
This lack of medication-specific training for dispensing staff in dispensing practices was a concern 
since these practices tend to be managed as an isolated independent unit. One participant identified 
a desire for dispensing practices to have better links with community pharmacy in order to improve 
educational levels as well as increase the level of support currently offered for less trained staff. 
4.4.2 Patient Educational Needs 
Healthcare professionals identified a number of educational opportunities for patients, the first being 
around informing patients of the protocols surrounding solutions or specials: 
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 ?I mean, we had one the other day and the man isn't that well but he's been on these 
tablets before and he knew it took a few days before but I think he must have forgotten 
ďĞĐĂƵƐĞŚĞǁĂƐĐŽŵŝŶŐŝŶĨŽƌƚŚĞŵĂŐĂŝŶ ?ǇŽƵŬŶŽǁ they just kind of look a bit 
disappointed and wish that they were there straight away. ? (Pharmacist) 
Raising awareness for patients that specials and possibly other formulations need to be ordered in 
advance would prevent these issues and would avoid patients waiting for their medication to arrive.  
One participant also identified that some patient education around controlled drugs, what they are 
and what they might mean, could be beneficial: 
 “ ?WĂƚŝĞŶƚƐ ?ŶĞĞĚƚŽďĞĞĚƵĐĂƚĞĚŝŶǁŚĂƚ ?ŽƉŝĂƚĞƐ ?ĂƌĞĂŶĚŚŽǁƚŽƵƐĞƚŚĞŵ ?/ŚĂǀĞƚŽ
ƐƉĞŶĚƚŝŵĞƚĂůŬŝŶŐƚŽƉĞŽƉůĞĂďŽƵƚŵŽƌƉŚŝŶĞĂŶĚƚŚĞĨĂĐƚƚŚĂƚŝƚ ?ƐŶŽƚĂĚĂŶŐĞƌŽƵƐƚŚŝŶŐ
and it should be used carefully and people should use enough of it and that all takes 
ƚŝŵĞ ?/ĚŽĨŝŶĚƉĂƚŝĞŶƚƐǁŚŽǇŽƵƚŚŝŶŬƐŚŽƵůĚďĞĞĚƵĐĂƚĞĚ and know about their opiates 
ĂŶĚƚŚĞǇĚŽŶ ?ƚƋƵŝƚĞƐĞĞŵƚŽŚĂǀĞŐƌĂƐƉĞĚŝƚǇŽƵŬŶŽǁ ?WĞŽƉůĞŶĞĞĚƚŽďĞƚŽůĚƚŚŝŶŐƐ
several times. ? ?KSL6) 
 
Not only would this level of education be beneficial in ensuring patients are using their opiates 
correctly, but may also be useful in dispelling any myths around controlled drugs. This particular 
participant commented that patients sometime have a negative attitude towards opiates because of 
the inaccurate association with illegal street drugs and the ill effects these can have on the body.  
4.4.3 Suggestions for Defining the MRWW ?ƐZŽůĞ 
Participants had a few ideas as to how they would like to see the MRPP role develop within the 
current service. The following table details the suggestions participants contributed during the 
interviews. 
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Table 4- Suggested Roles for Macmillan Rural Pharmacist Practitioner (MRPP) 
Suggested Role Supportive Quote 
Provide specialist advice for 
healthcare professionals on 
palliative drugs.  
 “ ?dŚĞMRPP ?Ɛ ?ŐŽƚƚŚĞŬŶŽǁůĞĚŐĞĨŽƌĂŶǇƚŚŝŶŐƚŽĚŽǁŝƚŚƉĂůůŝĂƚŝǀĞĚƌƵŐƐ ?ǁĞĐŽƵůĚ
phone her directly and let her sort it out and she would probably, hopefully have the 
time to be ĂďůĞƚŽĨŽĐƵƐŽŶŝƚ ?ƐŽƚŚŝŶŬƚŚĂƚ ?ƐŐŽŝŶŐƚŽďĞĂŚƵŐĞďŽŶƵƐ ? ?(KSL1) 
 
 “/ƚŚŝŶŬŝƚ ?ƐŐŽŽĚƚŽŚĂǀĞƐŽŵĞďŽĚǇǁŚŽŚĂƐĂƐƉĞĐŝĂůŝƐŵ in that or a real interest in 
ƉĂůůŝĂƚŝǀĞ ĐĂƌĞ ? ƚŚĞ ĨĂŵŝůŝĞƐĂƌĞ ƐƵƉƉŽƌƚĞĚ ? ƚŚĞ ĐůŝĞŶƚƐ ĂƌĞ ƐƵƉƉŽƌƚĞĚ ? ƚŚĞ ǁŽƌŬĞƌƐ
ĂƌĞƐƵƉƉŽƌƚĞĚĂŶĚƚŚĞĐŽŵŵƵŶŝƚǇ ?ƐƐƵƉƉŽƌƚĞĚƐŽŝƚ ?ƐƌĞĂůůǇŽĨďĞŶĞĨŝƚ/ƚŚŝŶŬ ? ?(KSL2) 
Influence and monitor the 
management of medicines in 
all settings. 
 “tĞǁŽƵůĚůŝĂŝƐĞĐůŽƐĞůǇǁŝƚŚ ?ƚŚĞMRPP] and if there were any issues with regard to 
ĐŽŶƚƌŽůůĞĚ ĚƌƵŐƐ Žƌ ǁŚĂƚĞǀĞƌ ƚŚĂƚ ǁĞ ǁĞƌĞŶ ?ƚ ŵĂǇďĞ ŐĞƚƚŝŶŐ ? ƐŚĞǁŽƵůĚ ŝŶĨůƵĞŶĐĞ
that with [the community pŚĂƌŵĂĐǇ ? ĂŶĚ ŵĂŬĞ ƐƵƌĞ ? ƚŚĂƚ ǁĞ ĚŝĚ ŚĂǀĞ ĞŶŽƵŐŚ ? ? 
(KSL1) 
 
 “ ?dŚĞMRPP ? ĐŽƵůĚ ŚĂǀĞ ƋƵŝƚĞ Ă ůŽƚ ŽĨ ŝŶƉƵƚ ŝŶ ƚŚĞ ƉĂƚŝĞŶƚƐ ? ƐŽƌƚ ŽĨ ŵĞĚŝĐĂƚŝŽŶ ? ?
[one] care home has quite unskilled workers with the patients and their 
ƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨŵĞĚŝĐĂƚŝŽŶŝƐŶ ?ƚĨĂŶƚĂƐƚŝĐ ? ? (Pharmacist) 
Provide a general pharmacy 
presence in community 
hospitals, care homes and 
dispensing practices.  
 “dŚĞĨŝƌƐƚƚŚŝŶŐŝƐĂĐƚƵĂůůǇŚĂǀŝŶŐƐŽŵĞďŽĚǇphysically here who will come in and talk 
ĂŶĚ ǁŝůů ƚŚŝŶŬ ĂďŽƵƚ ƉŚĂƌŵĂĐǇ ŝƐƐƵĞƐ ?ŚĂǀŝŶŐ ƐŽŵĞďŽĚǇ ǁŚŽ ŝƐ ƉƵƌĞůǇ ĨŽĐƵƐŝŶŐ ŽŶ
the medication issues is bound to be a source of support and help and improve 
standards, improve education, improve dissemination of practice from the ĐĞŶƚƌĞ ? ? 
(KSL6) 
Act as a link between 
healthcare professionals and 
organisations/resources.  
 “I think the new role here for the pharmacy here will [link] with some of our charity 
organisations such as Skye Cancer Care and you know sort of looking at how that 
ĐŚĂƌŝƚǇĐŽƵůĚƉĞƌŚĂƉƐďĞŝŶĨůƵĞŶƚŝĂůŝŶƐƵƉƉŽƌƚŝŶŐůŽĐĂůŝŶŝƚŝĂƚŝǀĞƐ ? ?(KSL7)  
Facilitate and/or provide 
training opportunities for 
staff.  
 “/ƚŚŝŶŬŝƚ ?ƐĂďŽƵƚũƵƐƚĞŶƐƵƌŝŶŐƚŚĂƚƚŚĞƌĞŝƐŽŶ-going training of all of our staff, that 
people are up to speed in all the latest developments around palliative care and 
palliative medicine ? ? ?KSL7) 
Act as a point of contact and 
advice directly for patients 
with palliative needs.  
 “Dealing with the patients, dealing with the other health professionals around them 
and sort of being a centre ? ? ?KSL8) 
 
4.5 Summary  
The project area faces several challenges due to its geography and other unavoidable infrastructural 
elements, yet healthcare professionals working in the area exhibit good coping behaviours when 
faced with these challenges. It was apparent that there is no formal pharmacy input in the 
community hospitals, with the responsibility of checking and maintaining palliative medicine stock 
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levels falling on nurses. Improved and increased support in this area, provided by community 
pharmacy services and further helped by the MRPP, would be beneficial.  
 
Healthcare professionals were aware of the various sources of support and information both within 
and outwith the project area, meaning that although their community is classed as rural they are not 
completely cut off from services further afield. Participants highlighted a number of areas where 
excellent planning is in place, for example through the use of Just in Case boxes. Due to the nature of 
the community, continuity of care was reported because patients would often receive care from the 
same healthcare professionals throughout the course of their illness. There is also a familiarity 
between patients and healthcare professionals due to the close-knit nature of the community.  
 
The gaps highlighted in the service revolved mainly around education and training needs. GPs are 
perceived as the central profession around which the delivery of palliative care revolves. Participants 
were of the view that GPs require more training and support in awareness and knowledge of 
medicines used in palliative care but also in the legal requirements for writing prescriptions for 
controlled drugs.  However, given the low number of palliative patients, there is risk that healthcare 
professionals can become de-skilled over time.  Furthermore, staff in dispensing practices expressed 
a specific desire for more training about medicines. Providing the whole MDT with additional 
training and education support may alleviate the current pressure on GPs to be the authoritative 
source of palliative information, care and advice in the project area.  
 
Patient education was of interest also, mainly focusing around providing patients with more 
information on how best to organise the supply of their medicines. Additionally, the need for 
patients to have better understanding of opioids and other medicines may encourage a sense of 
empowerment, perhaps enabling them to discuss their care more freely with a variety of healthcare 
professionals. This may further ease the current burden placed on GPs.  
 
 
5 Results 2- Highland Hospice Phone Log Analysis 
Below is the analysis of the palliative medicines-related calls received and selected for audit.  
 
5.1 Results 2 
Ultimately, 11 telephone enquiries were logged during the eight weeks sampled. The calls came 
from Portree (n=5), Kyle (n=3) and Dunvegan (n=2), with one caller not specifying their location. 
Table 3 presents an overview of the Highland Hospice Calls.  Interestingly, the majority of calls 
(72.7%) were made by GPs and were made during working hours (63.6%).  
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Table 5-Overview of Highland Hospice Calls  
Demographic Information Numbers 
Where did the calls come from?  
 Portree 
Kyle 
Dunvegan 
Unknown 
5 
3 
2 
1 
When were the calls made?  
 
 
Out-of-hours 
During Work Hours 
4 
7 
Who made the calls?  
 GP* 
Macmillan Nurse 
Relative 
8 
2 
1 
*During one of these calls, the patient was also present 
 
 
The research team examined the log and had a telephone discussion with the project lead and the 
MRPP in order to clarify any points which were not clear. The following account is a combination of 
the information obtained both from the audit and from these telephone calls. The 11 calls logged 
are presented in Table 6 as nine individual patient cases, as one patient was the subject of three 
separate calls.  
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Table 6- Palliative Medicine-Related Issues Collated on Summary Document from Highland Hospice Phone Log 
Case  Time Caller Nature of call Outcome/Advice Given 
1 Out-of-Hours GP The patient was suffering from headaches and had been 
prescribed medication with some improvement.   
dŚĞ 'W ĂŶĚ ,ŽƐƉŝĐĞ ĚŝƐĐƵƐƐĞĚ ƐƉƌĞĂĚŝŶŐ ƚŚĞ ƉĂƚŝĞŶƚ ?ƐĚŽƐĞ
throughout the day. The Hospice also recommended that the GP 
consider prescribing an alternative if use of the current medication 
caused issues.  
2 During Work 
Hours 
Macmillan 
Nurse 
dŚĞƉĂƚŝĞŶƚ ?ƐĐƵƌƌĞŶƚƉĂŝŶŵĞĚŝĐĂƚŝŽŶŚĂĚďĞĞŶŝŶĐƌĞĂƐĞĚďƵƚ
the patient had concerns about side effects.  
dŚĞƉŽƐƐŝďŝůŝƚǇŽĨƌĞĚƵĐŝŶŐƚŚĞƉĂƚŝĞŶƚ ?ƐĚŽƐĞŐƌĂĚƵĂůůǇǁŚŝůĞ
maintaining an adequate level of pain relief was discussed. 
3 During Work 
Hours 
GP The patient could no longer swallow so the GP was looking for 
advice on an alternative route of administration. 
Advice was given about injectable options and the use of a syringe 
pump. 
4 During Work 
Hours 
GP A patient had been prescribed a pain relief patch and had 
become toxic.  
The Hospice recommended that the GP cut the patch in half as a 
smaller dose was not available.  
5 Time 
Unknown 
GP A patient was struggling with pain and was unable to swallow.  The Hospice recommended that the patient be admitted to Hospital. 
6 During Work 
Hours 
GP A patient was experiencing unpleasant symptoms. The current 
medicines were re-evaluated in order to assess what the cause 
may be. 
An alternative medication and dose was recommended in order to 
control symptoms. 
 
7 Call 1: 
During Work 
Hours 
GP The patient had complex pain issues and was on a number of 
medications. The GP telephoned the Hospice for advice on what 
to prescribe to control the pain.  
The Hospice gave advice on current medications.  
Call 2: 
During Work 
Hours 
GP & 
Patient 
The patient had requested a stronger form of pain relief.  The Hospice explained that there were other alternatives still 
available at this point in time. 
Call 3: 
Time 
Unknown 
Relative of 
Patient 
dŚĞƉĂƚŝĞŶƚ ?ƐƉĂŝŶŚĂĚŝŶĐƌĞĂƐĞĚ ? The patient was prescribed the stronger pain medication.  The 
relative telephoned six days later to say there had been some 
improvement, and that the dose had been increased. The relative 
agreed to telephone with another update the following day.  
8 Time 
Unknown 
 
 
Macmillan 
Nurse 
The information in this entry was sparse, but it was assumed that 
the Macmillan Nurse was enquiring about the feasibility of a 
blood transfusion for a patient.  
No follow-up given. 
 
 
9 Out-of-Hours 
 
GP The patient was having draining procedures on a regular basis. 
The option of fitting a more permanent drain (PleurX) to make it 
more convenient for the patient was discussed.  
The Hospice advised that although conventional draining was 
feasible, a more permanent solution should be sought if current 
draining reached 3 to 4 times per week.   
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5.2 Summary  
The Highland Hospice Phone Line appears to be used mainly by GPs and the Macmillan Nurses, with 
occasional patient/relative use. The calls are a mixture of seeking advice / support for clinical 
decisions or confirmation for decisions already made.  Based on the information given on these calls, 
the phone line seems to be used mostly during work hours.    
 
6 Results 3: Care Home Questionnaire Analysis 
 
The questionnaire included a number of sections. Section 1 requested demographic information 
from care home staff; Section 2 included questions around any queries staff may have about 
medicines; Section 3 contained questions around the specifics of administering palliative care 
medicines which may require calculation (i.e. liquids); Section 4 asked participants about accessing 
palliative care medicines; and Section 5 focused on written materials on palliative care, training and 
support needs.  
 
Below is the analysis of the Care Home Questionnaire data.  
 
6.1 Results 
Four care homes (67%) returned 21 questionnaires.  Due to the small number of questionnaires 
returned, detailed analysis was not possible and hence summary descriptive statistics have been 
reported.  
 
NB Some questions allowed respondents to select more than one answer. 
 
 
 
Section 1: Demographic Data 
The sample consisted of two main job roles represented in the sample were registered general 
nurses (RGNs) and social carers. Just over half of the sample was employed full-time. Table 7 displays 
the full extent of demographic information collected. 
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Table 7- Care Homes, Job Roles and Working Hours of Respondents (n=21) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 2: Queries  
dŚĞ ƉĂƚŝĞŶƚ ?Ɛ 'W ƚĞŶĚƐ ƚŽ ďĞ ƚŚĞ ĨŝƌƐƚ ƉŽƌƚ ŽĨ ĐĂůů ĚƵƌŝŶŐ ǁŽƌŬ ŚŽƵƌƐ ĨŽƌ ƋƵĞƌŝĞƐ ĂďŽƵƚ ĚŽƐĞƐ Žƌ
administration of palliative care medicines.  Interestingly, none of the respondents reported 
contacting their local Community Pharmacist, the Highland Hospice, the Specialist Palliative Care 
Pharmacist, their local hospice or any other individuals or organisations during work hours. This 
ŝŶĚŝĐĂƚĞĚĚĞƉĞŶĚĞŶĐĞŽŶƚŚĞƉĂƚŝĞŶƚ ?Ɛ'WĨŽƌƉĂůůŝĂƚŝǀĞŝŶĨŽƌŵĂƚŝŽŶĂŶĚĂĚǀŝĐĞĚƵƌŝŶŐǁŽƌŬŚŽƵƌƐ ?
For out-of-hours period, thĞƉĂƚŝĞŶƚ ?Ɛ'WǁĂƐƚŚĞƐĞĐŽŶĚŵŽƐƚƉŽƉƵůĂƌƌĞƐƉŽŶƐĞ ?ŶA? ? ? ?ĂĨƚĞƌE,^ ? ? ?
Some participants reported contacting the GP on-call or specified the GP on-call at the local hospital. 
It is important to note that the GP on-ĐĂůůŵĂǇŶŽƚďĞƚŚĞƉĂƚŝĞŶƚ ?ƐĐƵƌƌĞŶƚ'P.   
 
Although the Highland Hospice does provide a palliative care-specific telephone advice service (the 
Highland Hospice Phone Line), only one respondent said that they would use this service out-of-
hours.  The local Community Pharmacist, Macmillan nurses and the Specialist Palliative Care 
Pharmacist were not mentioned (Figure 2).  
                                               
5
 All percentages have been rounded to the nearest whole per cent 
 Care Homes N (%
5
) 
   
 Care Home A 2 (10%) 
 Care Home B 6 (29%) 
 Care Home C 10 (48%) 
 Care Home D 3 (14%) 
 Job Roles of Respondents  
   
 Registered General Nurse 5 (24%) 
 Social Carer 5 (24%) 
 Carer 2 (10%) 
 Senior Carer 2 (10%) 
 Night Social Carer 2 (10%) 
 Senior Social Carer 2 (10%) 
 Manager 2 (10%) 
 Deputy Manager 1 (5%) 
Working Hours of Respondents  
   
 Full-Time 12 (57%) 
 Part-Time 6 (29%) 
 Relief Work 2 (10%) 
 No Response 1 (5%) 
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&ŝŐƵƌĞ ? P “/ĨǇŽƵŚĂǀĞĂƋƵĞƌǇĂďŽƵƚƚŚĞdose or administration of a palliative care medicine who would you 
ĐŽŶƚĂĐƚĨŝƌƐƚ ? ? ?ZĞƐƉŽŶƐĞƐ ?ŶA䄃? ? ?EŽZĞƐƉŽŶƐĞA䄃? ? 
 
dŚĞƉĂƚŝĞŶƚ ?Ɛ'WǁĂƐƚŚĞŵĂŝŶƐŽƵƌĐĞŽĨĂĚǀŝĐĞŽŶƚŚĞavailability and access of palliative care drugs 
for care home staff during work hours. Local community pharmacists were consulted, but only as 
frequently as the different nurses.  NHS 24 was accessed by one respondent.  Again, the Specialist 
Palliative Care Pharmacist and the local hospice were not cited as relevant contacts in this scenario 
(see Figure 5). These reports suggest that there are few problems in accessing medicines, but they 
also highlight the reliance on GPs (and nursing staff) for accessing these medicines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
&ŝŐƵƌĞ ? P “/ĨǇŽƵŚĂǀĞĂƋƵĞƌǇĂďŽƵƚƚŚĞavailability / access to a palliative care medicine during working hours 
(8am-6:30pm) - tŚŽǁŽƵůĚǇŽƵĐŽŶƚĂĐƚĨŝƌƐƚ ? ? ?ZĞƐƉŽŶƐĞƐ ?ŶA䄀  ? ? ?EŽZĞƐƉŽŶƐĞA? ? ? 
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&ŽƌŽƵƚŽĨŚŽƵƌƐ ?ƚŚĞŵŽƐƚƉŽƉƵůĂƌĐŚŽŝĐĞǁĂƐE,^ ? ?ŶA? ? ? ?ĨŽůůŽǁĞĚďǇƚŚĞƉĂƚŝĞŶƚ ?ƐŽǁŶ'W ?dŚĞ
Specialist Palliative Care Pharmacist and the local hospice were not cited reflecting the lack of formal 
community pharmacy involvement in other care settings across the project area, as well as a reliance 
on the GP for information and support.  
 
Section 3: Administering Medicines 
Participants were asked about administering medicines that could not be given by spoon or 
measuring cup. The most common method reported was using an oral syringe (n=18). The 
participants were also asked if intravenous syringes were used to measure or administer liquid 
medicines. Of the 17 who responded, 13 reported that this was not an acceptable method, yet four 
participants responded positively, providing additional comments justifying the use of an 
intravenous syringe only in very small doses or if the patient has trouble taking medicines orally.   
 
Section 4: Accessing Medicines 
Participants were asked various questions about the challenges, successes and circumstances in 
which they accessed palliative medicines.  
 
A small number of participants provided examples of good practice they experienced when 
accessing palliative medicines for their residents (n=6). These included:  the effective organisation 
and use of Just In CĂƐĞďŽǆĞƐ ?ƉĂƚŝĞŶƚƐ ?ƌĞŐƵůĂƌassessment; the involvement of care home staff and 
district nurses about the prescriptions written by GPs for palliative patients; and care home staff 
being able to request a prescription for palliative medicines from a particular GP and being able to 
access them right away.  
 
All participants stated that urgent prescriptions for residents were taken to the community 
pharmacy that the care home regularly used. One participant commented that in rare cases the GP 
will source medicines from the local hospital. When a prescription was urgent, participants said that 
face-to-face conversations with community pharmacy staff, nurses or GP surgery staff were the best 
way to express the urgent nature of the prescription (n=14). When care home staff could not 
communicate this in person, using the telephone was also used (n=5).  
 
Two participants reported problems in accessing palliative care medicines for residents in the last 
year. Of these, one was concerned with out-of-hours access to medicines and the other reported 
general issues with the supply of palliative medicines and concern for their future availability. 
Therefore, it appeared that in general care home staff did not experience issues in accessing 
palliative care medicines.  
 
Section 5: Written Materials, Training and Support 
This section of the questionnaire was designed to explore the use of named written materials 
specific to palliative care, as well as to identify current training and support needs of staff. 
Responses are detailed in Table 3.   
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Table 8- Responses to Questions on Written Materials, Training and Support (n and %) 
Question Yes No NR NA 
     
Do you regularly consult any written / published information 
resources on palliative care medicines? 
 
9 
(43%) 
11 
(52%) 
1 
(5%) 
- 
Do you have easy access to the NATIONAL PATIENT SAFETY 
AGENCY- ALERT 19; Promoting safer measurement and 
administration of liquid medicines via oral and other enteral 
routes? 
- 13 
(62%) 
7 
(33%) 
1* 
(5%) 
Do you have access to the NATIONAL PATIENT SAFETY AGENCY -
Rapid Response Report; Reducing Dosing errors with Opioid 
Medicines? 
- 14 
(67%) 
6 
(29%) 
1* 
(5%) 
 
 
Do you feel that you are sufficiently trained in calculating doses 
of any injectable medicines? 
 
5 
(24%) 
4 
(19%) 
11 
(52%) 
1 
(5%) 
Is there any further information, education or support you would 
like to receive in relation to palliative care medication? 
 
16 
(76%) 
3 
(14%) 
2 
(10%) 
- 
 
*NA= Not Aware of publication 
 
 
Less than half of respondents consulted publications on palliative care medicines. No participants 
reported accessing either of the National Patient Safety Agency documents which might suggest a 
lack of perceived usefulness of the documents. The majority of participants reported not having easy 
access to either of the documents. This is concerning as these documents contain important 
information which would be of use to care home staff when administering medicines and providing 
more general care for patients with palliative needs.  
 
Most respondents did not answer the question on calculating injectable doses. This suggests a lack 
of knowledge and an area the MRPP could develop with staff.  When asked about further 
information, education or support needs, most indicated that this was warranted.  One participant 
indicated training around the documents mentŝŽŶĞĚ ĂďŽǀĞ ?  KĨ ƚŚŽƐĞ ǁŚŽ ƌĞƐƉŽŶĚĞĚ  “ŶŽ ? ? ƚŚĞ
reason seemed to be that these participants were already undergoing training, with two individuals 
participating in a palliative care course provided by an external organisation. 
 
6.2 Summary  
The Care Home Questionnaire ĚĂƚĂŝŵƉůŝĞƐƚŚĂƚƚŚĞƉĂƚŝĞŶƚ ?Ɛ'WƐĂŶĚE,^ ? ?ĂƌĞƚŚĞŵŽƐƚƉŽƉƵůĂƌ
choices for staff when needing information about medicines, both during and out of working hours.  
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The Community Pharmacist is not considered as a source of advice.  In addition, the Specialist 
Palliative Care Pharmacist and Macmillan nurses were also not cited as sources of support.   
 
Technology appears to be is poorly utilised perhaps due to unreliable connections in the area. Staff 
appear to prefer face-to-face contact with pharmacy staff when explaining the urgency of palliative 
prescriptions.  Informal discussions with the MRPP reveal that most situations are dealt with face-to-
face. A desire for better communication is evident. A potential role for the MRPP may be to help 
reinforce relationships between personnel in the care homes and other staff across the project area.  
 
Participants did not consult the written palliative care resources mentioned. This suggests that these 
documents were not perceived as relevant for their job role. This coupled with the expressed need 
for more training suggests care home staff do not feel they are aware of all of the resources or 
guidelines needed in palliative care. Another factor is that due to the perceived small numbers of 
palliative patients, there may be times when care homes will possibly not have any residents with 
palliative needs, and therefore staff can become de-skilled. It is reassuring that some care home 
staff are currently undergoing palliative care training in order to address these needs.  
 
7 Conclusions 
 
This report is the first output from the evaluation program and focuses on the investigation to 
characterise the provision of community pharmacy services within the project area, identifying not 
only service gaps but identifying key issues which can be used to inform a quality improvement 
program.   
 
In particular, this report can be used to support an action plan to enhance the current service 
provision, by supporting the wider healthcare team and provide a focus for the evolving role of the 
MRPP.  Since a wide range of healthcare professionals were consulted the findings are a relatively 
comprehensive mapping of current service provision.  
 
7.1 Strengths of the Evaluation 
A wide range of healthcare professionals from across the project area were sampled. Furthermore, 
differing settings were also explored, such as settings in larger towns and in smaller rural villages. 
Both professional and patient experiences were intended to be captured via the Highland Hospice 
Phone Line Audit. Data collection was arranged in a time-efficient manner, utilising both face-to-face 
and distance methods in order to capture as many experiences as possible. Data collection time was 
therefore used to its maximum potential. The data collection periods for the Highland Hospice 
Phone Line Audit and the community pharmacy and nursing logs were initially scheduled to coincide 
completely to capture the issues experienced in one particular point in time. Due to the low volume 
of issues captured, these times partially coincided. Complete support was given by all Stakeholders 
involved, resulting in ease of data collection.  
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7.2 Limitations of the Evaluation 
Through discussions with the steering group, it was realised that some aspects of the service were 
not explored during this baseline period of work.  The perspective of patients and carers was not 
ĚŝƌĞĐƚůǇ ƐĂŵƉůĞĚ ?  dŚĞ ŽƌŝŐŝŶĂů ĚĞƐŝŐŶ ĂŶƚŝĐŝƉĂƚĞĚ ƚŚĂƚƉĂƚŝĞŶƚƐ ? ǀŽŝĐĞƐ ǁŽƵůĚ ďĞ ŚĞĂƌĚ ĚŝƌĞĐƚůǇ
through the Highland Hospice Phone Line Audit and indirectly from the frontline healthcare 
professionals surveyed and interviewed.    Additionally, it was identified that nursing staff may not 
feature as heavily in the baseline report in relation to their central role in service provision.   Nursing 
staff were asked to complete logs of issues around palliative medicine use, and members of the 
research team contacted them to discuss their reported issues. These logs did not identify a great 
number of issues, and this may be reflective of minimal issues over the short data collection period 
and/or the additional burden of documenting this activity for the purpose of the study. It may be 
that staff asked to complete the logs had difficulty in understanding what the University team meant 
ďǇ  ‘ƉĂlliative medicines-ƌĞůĂƚĞĚ ŝƐƐƵĞƐ ? ? ĂůƚŚŽƵŐŚ ĞǆĂŵƉůĞƐ ǁĞƌĞ ŐŝǀĞ ?It may be appropriate to 
undertake further in-depth data collection moving forward.  
 
Below we have outlined existing good practice, current challenges and potential future directions 
identified from the three studies:  
 
7.3 Current Strengths & Good Practice 
x The community within the project area is relatively stable, with little fluctuations in 
demographics out-with the tourist season. This means that demand for palliative services 
including medicines can be more predictable than other areas with a higher population 
turnover6 
x Healthcare professionals accept the environmental challenges posed by the project area  
and are able to effectively deal with these 
x There is a strong sense of community, whereby healthcare professionals go above and 
beyond to ensure patients receive the appropriate care 
x The current palliative care service is responsive to individual patient needs, both within and 
out-with working hours 
x Access to core medicines for palliative care is relatively easy and generally reliable 
x The Highland Hospice Phone Line is available to patients, carers and other healthcare 
professionals as a source of advice and support 24/7, but is primarily used by GPs.  
 
7.4 Current Challenges 
While issues such as weather, geography and population density cannot be controlled, their 
potential adverse effects can be addressed by resource planning and education / training. On the 
whole, little if any problematic issues were identified but greater use of formalised contingency 
planning would be helpful. Additionally, increasing the education provision throughout the MDT 
                                               
6
 This characteristic was established through informal discussions with the Steering group.  
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would improve the knowledge base, acting against a lack of experience due to lack of patients 
requiring palliative care. While professionals going  ‘above and beyond ? is admirable- and inevitable 
to an extent- effective forward planning must aim to reduce this to an acceptable minimum.  
A number of challenges were identified throughout the course of the evaluation period and can be 
categorised as follows: 
 
Education & Training 
x A lack of recognition amongst practitioners that palliative care applies to all progressive 
incurable diseases which no longer respond to active treatment. Consequently  the term 
 ‘ƉĂůůŝĂƚŝǀĞ ? potentially applies to a larger population than currently defined 
x Care home staff generally lack awareness of the population of palliative patients in their 
care homes, and suffer a lack of confidence in their abilities to recognise, support and 
aĚĚƌĞƐƐƉĂƚŝĞŶƚƐ ?ŶĞĞĚƐ 
x Dispensing staff within dispensing practices are not compelled to undertake any formal 
medicines training.  Training is made available through NHS Highland Health Board 
funding but there appears to be variable access and uptake. The benefits of undertaking 
specific training may need to be more acutely demonstrated to dispensing staff  
x Knowledge of more specialist palliative medicines such as specials, particular 
formulations and controlled drugs is rather limited, largely because of the perceived low 
number of palliative care patients treated at any one time. 
 
Integration of the Pharmacist into the MDT 
x There is a lack of understanding amongst the wider MDT of the knowledge, skills and 
expertise of the Community Pharmacist and the Area Specialist Palliative Care 
Pharmacist. This often results in an over-reliance on the GP when it comes to advice 
about palliative care medicines 
x The pharmacist should be considered a key resource not only for advice concerning 
palliative medicine but should also be integral in care planning such as Gold Standard 
Review meetings 
x The community hospitals currently lack access to pharmaceutical input including support 
with medicines management plus clinical pharmacy advice 
x Patients generally lack understanding around the safe and appropriate use of opioids 
and potentially other medicines. The Community Pharmacist is ideally placed to address 
this. 
 
Forward Planning 
x Many healthcare professionals go above and beyond to deliver care. Although this 
ƌĞĨůĞĐƚƐ ƚŚĞ ŚĞĂůƚŚĐĂƌĞ ƉƌŽĨĞƐƐŝŽŶĂůƐ ‘dedication to providing excellent care, it shows 
that there may not be sufficient plans or procedures in place to deal with particular 
situations 
x There is large expectation on the GP as source of advice, support and as a care provider. 
This often results in the inappropriate use of the GPƐ ? ƚŝŵĞ ? ďŽƚŚ ǁŝƚŚŝŶ ĂŶĚoutwith 
normal working hours 
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x There need to be suitable mechanisms in place to provide awareness amongst the MDT 
of current pharmaceutical practice appropriate to their settings.  
 
7.5 Quality Improvement Plan 
Based on the challenges identified, and through discussions with the Steering Group, the next 
section details current service innovations as well as potential areas for further work to address 
these challenges (illustrated in Figure 4).   
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The Audit will determine the 
prevalence and nature of 
interventions made by community 
pharmacy and dispensing practice 
staff when presented with a 
prescription for CDs for palliative 
care.  
 
The MRPP will devise  and 
disseminate  training materials 
for different embers of the 
MDT on ǀĂƌŝŽƵƐ ‘ƉŚĂƌŵĂĐǇ ?
medicines- type  topics with 
the aim of  improving  the 
knowledge of  those caring for 
palliative care patients.  
 To date, the MRPP has liaised 
with GPs and Nursing staff in 
developing educational 
materials displaying 
conversion doses for opioids, 
anticipatory prescribing guides 
and guidance on correct CD 
prescription writing. 
 
To raise the profile of the MRPP, a fortnightly drop-in clinic within Portree Pharmacy for 
patients/carers with palliative needs is in operation. Service users can discuss with the MRPP 
any issues or questions relating to medicines. The clinic was advertised in most media began 
operation in September 2013. Data is being collected on:  interventions made as a result of 
clinic attendance; service user satisfaction; and suggestions around how the service can be 
improved.  
 
The Steering Group articulated 
that some patients in the 
project area struggle with 
literacy. The project area also 
welcomes visitors from other 
countries during the tourist 
season. Ensuring patients 
understand the written 
information on their medicines 
is of importance. The existing 
literature on literacy or 
language barriers in 
healthcare will be explored, as 
well as other approaches 
taken to address this 
challenge. The potential use of 
alternative information aides 
will be explored.  
 
A need for patient education 
concerning opioid use was identified. 
This involves challenging e the 
misconceptions surrounding opioid use 
within the patient and carer 
population.  
 
The possibility of developing Prescribing 
Clinics where patients could discuss their 
prescriptions and have them reassessed if 
necessary by an independent prescriber 
within the community pharmacy has been 
explored. This service aims to increase the 
profile of the community pharmacist; 
alerting patients to the support that the 
pharmacist can offer.   
 FORWARD PLANNING 
EDUCATION & TRAINING 
INTEGRATION OF THE 
PHARMACIST INTO THE MDT 
 
Figure 4: Activities Currently in Place and Areas for Further Work 
The MRPP is currently attending 
all Gold Standards Framework 
meetings in order to facilitate 
the future involvement of the 
community pharmacist in wider 
MDT activities. Furthermore, 
other healthcare professionals 
not previously engaged in these 
meetings are being encouraged 
to attend by the MRPP.  
MRPP attendance at 
GSF meetings 
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9 Appendices 
Appendix 1- Dispensing Practice Staff Interview Schedule 
 
 
1. How did you get into this job? 
PROMPT: Specific training  
 
 
 
 
2. Are there any medicine-type issues that you routinely face when presented with a palliative 
care prescription? 
PROMPT: Patient concerns about community awareness of illness (e.g. attending 
pharmacy with prescription etc.)  
 
 
3. At present how do you resolve the issues? 
 
 
 
4. Do the patients ever discuss any palliative medicine-type issues with you? 
PROMPT: Issues with prescription at pharmacy 
PROMPT: Out-of-hours  
PROMPT: Security issues around controlled drugs  
 
 
 
 
5. Do you have any suggestions for improving the current service 
PROMPT: Additional training  
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Appendix 2- GP Interview Schedule 
 
1. Are there any medicine-type issues that you routinely face for these patients? 
 
 
 
2. Do the patients ever discuss their palliative medicine-type issues with you? 
PROMPT: Issues with prescription at pharmacy 
PROMPT: Out-of-hours  
PROMPT: Security issues around controlled drugs  
PROMPT: Patient concerns about community awareness of illness (e.g. attending 
pharmacy with prescription etc.)  
 
 
3. The issues we have spoken about, at present how do you resolve these issues? 
 
 
 
 
4. Do you have any recommendations for addressing these issues?  
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Appendix 3- Key Service Lead (KSL) Interview Schedule 
 
1. Are there any medicine-type issues or problems that routinely occur in your area? 
 
 
 
 
 
2. The issues we have spoken about, at present how do you resolve these issues? 
 
 
 
 
 
3. What are the strengths and weaknesses of the current service? 
 
PROMPT: Resources 
PROMTP: Geography 
 
 
 
 
4. What would be your recommendations for improving the service? 
PROMPT: Local examples of best practice  
PROMPT: Improve patient care 
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Appendix 4- Interview Information Sheet, Consent Form and Demographics Sheet 
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Appendix 5- Community Pharmacy Log 
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Appendix 6- Community Nursing Log 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  51 
Appendix 7- Highland Hospice Phone Line Audit Summary Document 
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Appendix 8- Care Home Information Sheet and Questionnaire 
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